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DEVELOPMENT OF NOVEL BIOCATALYSTS FOR INDUSTRIAL 
APPLICATIONS 
SUMMARY 
Global warming and the resultant problems have made the scientific community and 
general public  realize that there is a need to decrease dependency on oil for energy. 
It has also shown the need to increase the efficient use of energy in manufacturing 
and industrial processes. Green processes would be an alternative way of decreasing 
oil dependency and biotechnology is promoted as a way both to decrease oil 
dependency and as a source for renewable bio-based products.  
Biocatalysis (using enzymes or whole systems) can provide a valuable alternative to 
traditional chemical processes because it has many advantages such as; efficiency in 
enhancing the rate of chemical reactions and for their ability to discriminate between 
potential substrates. Therefore there is the possibility of using biological molecules 
to catalyse any reaction or modify any product of interest to industry.  
Biological catalysts from animal, plant and bacterial sources have evolved to perform 
most types of organic reactions, producing chirally pure and complex molecules with 
interesting biological properties. Biocatalysts have thus become important tools in 
medicine, the chemical industry, food processing and in agriculture. Industrial 
processes often require extreme conditions such as high pressure, temperature and 
extreme pH which require a large amount of energy to achieve and may produce 
unwanted toxic waste. Biological enzymes do not require such conditions and 
produce chirally pure products often without the disadvantages of unwanted toxic by 
products. 
The use of naturally occurring enzymes is not that common because of limited 
substrate and coenzyme specificity and kinetic problems with the reactions. Protein 
engineering is a promising approach which can be used to create enzymes with the 
desired properties. Enzymes can also be engineered to better understand the 
molecular basis for their functions so that they will be able to synthesize novel 
products in non-native environments.  
Here, we have aimed to improve the substrate specificities of two industrially 
important enzymes namely; Bacillus stearothermophillus lactate dehydrogenase 
(bsLDH) and  Rhodotorula graminis phenylalanine amonyum lyase (rgPAL). 
To improve the properties of these two enzymes, we have applied three routes of 
protein engineering studies namely; DNA shuffling, site directed mutagenesis and 
combinatorial active site saturation (CASTing). The substrate specificity of bsLDH 
was successfully altered by using DNA shuffling and site directed mutagenesis 
approaches. The activity of rgPAL for the selected different substrate(s) was also 
increased by CASTing.  
This thesis details various strategies used to produce novel bsLDH and rgPAL 
proteins. It is divided into three experimental sections. The first two sections describe 
xx 
 
to engineer bsLDH and the last section explains the application of CASTing method 
on rgPAL.  
bslactate dehydrogenase catalyses the interconversion of an oxo-acid (pyruvate) and 
hydroxy-acid (lactate) using the NADH/NAD
+
 pair as a redox cofactor. The enzyme 
has a commercial significance as it can be used to produce chiral building blocks for 
the synthesis of key pharmaceuticals and agrochemicals. Although bsLDH allows the 
synthesis of chiral hydroxy acids from their corresponding oxo-acids with high 
stereochemical fidelity, this enzyme has the disadvantage of generally not having 
very broad substrate specificity.  
In the first part of the thesis; DNA shuffling was used to alter the substrate specificity 
of bsLDH. The recombinant colonies having shuffled bsLDH are blotted and 
screened for their ability to catalyse the oxidation of malate.   
The shuffled mutant LDH has eight amino acid substitutions -Asn4Gln, Ser19Thr, 
Gln86Arg, Thr91Ser, Ala173Val, Glu183Asp, Gln221Asn and Val267Thr- changing 
the substrate specificity of bsLDH from pyruvate / lactate to malate / oxaloacetate.  
The eight amino acid substitutions led to a new malate dehydrogenase that catalysed 
the oxidation of malate 1009 times faster than the pyruvate does. This result 
demonstrates that the blind shuffling can achieve a huge shift in specificity which 
was a known, highly effective single-site mutation designed using structural 
knowledge. 
In the second part of the thesis; we described attempts to change the reactivity of 
bsLDH towards L-mandelic acid. Using the Insight II molecular modelling program 
and protein engineering techniques, we have successfully introduced substantial 
mandelate dehydrogenase activity to the enzyme. Energy minimisation modelling 
studies suggested that two mutations, Thr246Gly and Ile240Ala, would allow the 
enzyme to utilise L-mandelic acid as a substrate.  
Genes encoding for the wild type and mutant enzymes were constructed, and the 
resulting bsLDH proteins were overexpressed in E. coli and purified using the 
TAGZyme system . Enzyme assays showed that insertion of this double mutation to 
the highly purified bsLDH switched the substrate specificity from lactate to L-
mandelic acid.  
In the last part of the thesis, our aim was to increase the enzymatic activity of the 
phenylalanine ammonia-lyase (PAL) from Rhodotorula graminis for non-natural 
specific substrates.  
PAL catalyses the non-oxidative conversion of L-phenylalanine (L-Phe) to trans-
cinnamic acid (t-CA). The reversibility of this reaction has been used to synthesise 
analogues of L-phenylalanine as pharmacophores in several peptidomimetic drug 
molecules and are therefore of particular interest to the fine chemical industry. 
Five (5) libraries were set up, with at least two residues in each library, around the 
active site based on CASTing method that is a semi rational design. The degenerate 
codon NRT was used for all libraries. A total of 2000 colonies were screened using a 
developed assay 1 and after several rounds of screening, four PAL variants which 
displayed activity against selected substrate. 
Two assays have been developed for facilitating the identification of PAL variants. 
The first one is applied for screening libraries and measuring the formation of t-CA 
during the deamination. In the second assay, an oxidase enzyme (as a reporter 
xxi 
 
enzyme) is coupled for allowing the detection and quantification of phenylalanine 
production by PAL enzymes. 
Following the purification, the mutant bsLDH and rgPAL enzymes were kinetically 
characterised. Kinetic studies proved that the substrate specificities of bsLDH and 
rgPAL were successfully altered.  
These results imply that protein engineering is a powerful technology for enzyme 
redesign if an appropriate strategy is applied. 
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ENDÜSTRİYEL UYGULAMALAR İÇİN YENİ BİYOKATALİZÖRLERİN 
GELİŞTİRİLMESİ  
ÖZET 
Küresel ısınma odaklı tartışmalar ve bu konuda oluşan kaygılar son yıllarda bilim 
insanları ve toplum içinde giderek artmaktadır. Bu durum, petrol kaynaklı üretimler 
yerine yenilenebilir biyolojik kaynaklara yönelimi teşvik etmektedir. “Yeşil proses” 
olarak adlandırılabilecek biyokatalizörlerin farklı endüstriyel alanlarda kullanımının 
önemi yakın zamanda idrak edilmiştir.  
Kimyasal katalizörler yerine hayvansal, bitkisel ve bakteriyel kaynaklardan elde 
edilen enzimlerin kullanımı endüstriyel proseslerde çeşitli avantajlar sağlamaktadır. 
Kiral merkezli moleküllerin sentezi kimyasal yöntemlerle gerçekleştirildiğinde 
rasemik karışımlar elde edilmektedir.  
Enzimatik reaksiyonlar ise enantiomerik saflıkta ürün üretimine imkan 
verdiklerinden, biyokatalizörlerin kiral bileşik üretiminde kullanılması çok uygundur. 
Biyokatalizör kullanımının diğer avantajları enzimlerin biyobozunur olmaları, 
katalizledikleri reaksiyonda stereo-seçici, bölgesel-seçici ve kimyasal-seçici 
davranmaları, görece düşük sıcaklıkta, ılıman pH ve basınç koşullarında fonksiyon 
göstermeleri ve çevre dostu olmaları şeklinde sıralanabilir. Bu avantajlarından dolayı 
biyokatalizörlerin tıp, kimya, gıda üretimi ve tarım endüstrilerinde kullanım alanları 
giderek artmaktadır.  
Fakat doğal çevreden izole edilen enzimlerin doğrudan endüstriyel proseslerde 
kullanılabilmeleri herzaman mümkün olmamaktadır. Enzim karakteristik 
özelliklerinin (aktivite, stabilite, çözünürlük, substrat ve koenzim seçiciliği ve 
optimum pH aralığı) sıklıkla ilgili endüstriyel üretime göre optimize edilmesi 
gerekmektedir. 
Protein mühendisliği yöntemleri, ilgili proses koşullarına uygun enzimlerin dizayn 
edilmesine olanak tanımaktadır. Protein mühendisliği, moleküler biyoloji 
tekniklerinin kullanılması yolu ile enzimlerin yapı ve fonksiyonlarının moleküler 
düzeyde anlaşılıp, genetik yapılarının değiştirilerek, istenilen yapı ve fonksiyona 
sahip yeni enzimlerin üretilmesini mümkün kılmaktadır. 
Burada, endüstriyel öneme sahip olan Bacillus stearothermophillus laktat 
dehidrogenaz (bsLDH) ve Rhodotorula graminis fenilalanin liyaz (rgPAL) olarak 
adlandırılan enzimlerin substrat özgüllüklerinin  iyileştirilmesini hedefledik.  
Bu iki enzimin özelliklerinin iyileştirilmesi için protein mühendisliğinin üç yöntemi 
uygulanmıştır; DNA shuffling (DNA karıştırma), bölgeye özel mutasyon 
yaklaşımları ile kombinatoryal saturasyon aktif bölge testi (CASTing).  
bsLDH’ın substrat spesifikliği, DNA karıştırma ve bölgeye özel mutasyon 
yaklaşımları ile başarıyla değiştirilmiştir. rgPAL’ın aktivitesi ise seçilen farklı 
substratlara karsı CASTing yöntemi kullanılarak arttırılmıştır. 
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Bu tez kapsamında yeni bsLDH ve rgPAL proteinlerinin üretilmesine yönelik farklı 
stratejiler detaylı bir şekilde incelenmiştir. Üç deneysel bölümden oluşan tezin ilk iki 
bölümü bsLDH’ın düzenlenmesini tanımlarken, son bölüm rgPAL için CASTing 
metodunun uygulanmasını açıklamaktadır. 
bsLDH, okzo-asitlerin (pirüvat) hidroksi asitlere (laktat) karşılıklı dönüşüm 
reaksiyonunu NADH/NAD+ çiftini redoks kofaktörü olarak kullanarak katalizler. 
Enzim, eczacılık ve tarım alanında anahtar role sahip kiral moleküllerin sentezinde 
kullanılan ara ürünlerin üretiminde kullanıldığından ticari öneme sahiptir. İlgili okzo-
asitlerin kiral hidroksi asitlerinin yüksek stereokimyasal seçicilikle üretilmesine 
imkan vermesine rağmen; bsLDH enziminin en önemli dezavantajı son derece sınırlı 
substrat özgüllüğüne sahip olmasıdır.  
Tezin ilk kısmında; bsLDH’ın substrat seçiciliğini değiştirmek için DNA karışım 
yöntemi kullanılmıştır. DNA karışım yöntemi ile elde edilen rekombinant  mutant 
bsLDH kolonilerinden, malatın oksidasyonunu katalizleyebilenler uygun tarama ve 
seçme test yöntemi kullanılarakdiğerlerinden ayırt edilmişlerdir.  
Yönlendirilmiş evrim sonucunda sekiz (8) tane amino asit değişimine - Asn4Gln, 
Ser19Thr, Gln86Arg, Thr91Ser, Ala173Val, Glu183Asp,Gln221Asn ve Val267Thr- 
sahip olan mutant bsLDH proteininin substrat seçiciliğini pirüvat/laktatdan 
okzaloasetat/malata değiştirmiştir.  
Bahsedilen sekiz mutasyonun bsLDH’de malat dehidrogenaz aktivitesi oluşumuna 
neden olduğu ve  malatın oksidasyonunu, pirüvata kıyasla 1009 kat daha hızlı olacak 
şekilde gerçekleştirdiği görülmüştür. Bu sonuç, yapı bilgisi kullanılarak yüksek 
verimli tekli mutasyonlarla hedeflenenin gerçekleştirildiği tasarımlara göre, 
yönlendirilmiş evrimin de özgüllüklerde yüksek değişikliklere yol açabileceğini 
göstermiştir. 
Tezin ikinci kısmında; X-ışını kristal yapısı ve biriken literatür bilgisi kullanılarak 
bsLDH rasyonel olarakmandelik asitle reaksiyona girecek şekilde dizayn edilmiştir. 
Mandelat dehidrogenaz aktivitesi, InsightII moleküler modelleme programı 
kullanılarak; bsLDH enziminde oluşturulmuştur. Modelleme programı enerji 
minimizasyonu sonucunda; Thr246Gly ve Ile240Ala mutasyonları ile bsLDH 
enziminin L-mandelik asidi substrat olarak kullanabileceği gösterilmiştir.  
Mutanlar oluşturulmuş ve mutant gen E.coli‘ye aktarılarak sentezi 
gerçekleştirilmiştir. Ayrıca mutant ve doğal bsLDH‘i saflaştırmak için TAGZyme 
saflaştırma sistemi oluşturulmuştur. 
Rasyonel olarak tasarlanan bsLDH’ın aktivitesi mandelat varlığında ölçülmüştür. 
Enzim kinetiği sonuçları, bu iki mutasyonun, yüksek saflıkta elde edilen mutant 
bsLDH’ın substrat özgüllüğünü laktatdan L-mandelik asite dönüştürdüğünü 
göstermiştir. 
Tezin son kısmında; E.coli’ye ekspresyon vektörüyle klonlanmış Rhodotorula 
graminis kaynaklı fenilalanin amonyum liyaz (rgPAL) enziminin doğal olmayan 
amino asitlere karşı aktivite kazandırılmasını amaçladık.  
PAL, oksijensiz ortamda L-fenilalaninin trans-sinamik aside dönüşümünü 
katalizlemektedir. Bu reaksiyonun geri dönüşüm reaksiyonu, farmakoper olarak 
birçok peptidomimetrik ilaç molekülünün üretiminde L-fenilalanin analoglarının 
sentezinde kullanıldığından, enzim kimya endüstrisinde özel bir öneme sahiptir. 
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Yarı rasyonel dizayn olarak değerlendirilen CASTing metodu çerçevesinde, her bir 
kütüphane için en az iki tane amino asit içeren beş kütüphane oluşturulmuştur. NRT 
yıkıcı kodon olarak bütün kütüphaneler için kullanılmıştır. 2000 koloni, geliştirilen 
protokol 1 ile taranmıştır. Birçok tarama adımından sonra seçilen substrata karşı 
yüksek aktivite gösteren dört rgPAL varyantı belirlenmiştir. 
PAL varyantlarının tanımlanmasını kolaylaştırmak için iki tane test yöntemi 
geliştirilmiştir. Birinci test yöntemi, elde edilen kütüphaneleri taramak ve oluşan 
trans sinamik asit (t-CA) miktarını ölçmek için uygulanmıştır. İkinci test yönteminde 
ise, belirleyici enzim olarak kullanılan oksidaz enzimi, PAL enzimleri tarafından 
üretilen fenilalaninin miktarının kantitatif olarak ölçülmesine olanak tanıyacak 
şekilde eşleştirilmiştir. 
Uygun saflaştırma prosesleri sonrasında, mutant bsLDH ve rgPAL enzimleri kinetik 
olarak karakterize edilmişlerdir. Enzim kinetiği çalışmaları, bsLDH ve rgPAL 
enzimlerinin substrat özgüllüklerinin başarılı bir şekilde değiştirildiğini göstermiştir. 
Elde edilen bu sonuçlar, uygun strateji uygulandığında protein mühendisliğinin, 
enzimlerin yeniden tasarlanmasında çok güçlü bir teknoloji olduğunu göstermiştir.
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1. INTRODUCTION  
1.1 Evolution  
Charles Darwin started voyage of the Beagle in 1831 as a researcher. After 
completion of his voyage, precisely twenty-three years later, 1250 copies of his book 
“On the Origin of Species by Means of Natural Selection or the Preservation of 
Favoured Races in the Struggle for Life” was published [1]. In his book, Darwin`s 
main argument was, by gradual, step by-step transformations from simple 
beginnings, from primordial entities sufficiently simple to have come into existence 
by chance. Each successive change in the gradual evolutionary process were arisen 
by chance was simple enough and relative to its predecessor. Nevertheless, the whole 
sequence of cumulative steps constitutes anything but a chance process, when you 
consider the complexity of the final product relative to the original starting point. 
The cumulative process is directed by non-random survival [1]. 
Evolution shows that the change in all species living in nature in order to survive 
under different/hard environmental conditions has been stretched in a long time. In 
nature, species realize the best possible adaptation form for themselves by 
accumulated mutation(s) in their own genes. The processes of random mutation, 
recombination and natural selection act as if an “engineer” adapts a living organism 
with minimum change to the new conditions, but eliminates those species resisted to 
adapt to new conditions at the biological molecule level. This “engineer” was the fact 
of “natural selection” accumulated from Thomas Hobbes to David Hume, from 
Adam Smith to Thomas Robert Malthus and to Alfred R. Wallace, then finally to 
Charles Darwin [2].  
Each biological molecule has been optimized through evolution to perform its 
physiological task upon which all forms of life depend. Proteins are the major 
components of organisms and they are subject to natural selection, which promotes 
novel adaptive features or removes deleterious mutations.  
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1.2 Biocatalysts and DNA Technology 
One of the most important biological molecules are biocatalysts (referred to as 
enzymes) which have been naturally evolving over millions of years by accumulating 
mutations in the DNA of the genes which encode them. Biocatalysts are either 
proteins (enzymes) or, in a few cases, they may be nucleic acids (ribozymes). They 
are known as the most remarkable biomolecules because of their extraordinary 
specificity and catalytic power [3]. The specificity and (enantio- and regio-) 
selectivity of certain enzymatic transformations make them attractive for the 
researchers. In the natural environment, Darwinian evolution selects for the altered 
properties of enzymes.  Many enzymes catalyze very different reactions depending 
on where they are found.  However, enzymes have come about by divergent 
evolution from a common ancestral protein of the same general structure. Therefore, 
enzymes have been acquired diverse capabilities by the “engineer”. Enzymes have 
all the properties of ideal catalysts for various chemical reactions. In the presence of 
an appropriate enzyme, a chemical reaction occurs at a much higher rate and the 
enzymes still continue to survive in reaction environment. The most important 
feature of the enzymes is to perform very specific transformations that have made 
them more popular in industries where less specific chemical processes produce 
unwanted by-products. Purity and predictability are of particular importance in food 
manufacture, where by-products may be harmful or affect flavor, and because of 
their specificity, pharmaceutical producers prefer enzymes in the development of 
new drug. Because of their chiral and position selectivity they are used to produce 
fine chemicals, which are difficult to make using traditional organic chemistry. The 
importance of cleaner methods for industry grows as a greater awareness of 
conservation issue, so enzymes are significant for this area outside of the 
pharmaceutical and food industries. In the case of enzymes, however, the question 
whether they can also act as catalysts outside living systems had been of controversy 
among biochemists in the beginning of the twentieth century. Even there are not any 
discovered technological tools for transcription of the genetic code into ribonucleic 
acid (RNA) and translation of the information into protein biosynthesis, together 
with some methods used in genetic engineering, e.g. the transformation of 
deoxyribonucleic acid (DNA) into living cells. Although enzymes are formed within 
cells, they can continue to function in a test-tube and their ability to perform very 
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specific chemical transformations makes them increasingly useful in industrial 
processes. The use of industrial enzymes in the industry goes back as far as the 1930s 
for beverage industry, when Rӧhm&Haas launched the pectinase “Pectinol K” onto 
the market for the clarification of apple juice haze and in the 1960s with the use of 
glucoamylase to produce greater yields, higher purity and easier crystallization of 
glucose from starch [4-9]. 
In the late 1980s, a new technology was developed. This technology is based on the 
artificial manipulation and transfer of genetic material from one organism to another, 
called recombinant DNA technology. After the development of recombinant DNA 
technology, many things changed significantly in favor of protein based on 
biocatalysis. Molecular cloning and heterologous protein expression strategies 
facilitated the production of large quantities of recombinant biocatalysts much easier 
and produced cheaper than before. 
Enzyme–catalyzed processes have gradually replaced chemical processes in many 
areas of industry. In less than a century since the start of industrial enzyme 
production, biocatalyst technology and its products have steadily gained increasing 
importance. In the industrial production of materials to meet the demands of 
everyday life, biocatalysts have played an important role. Their application ranges 
from the production of processed foods such as bread, cheese, juice and beer 
(Table1.1). 
Table 1.1 : The industrial application of enzymes [10].  
Industry        Enzyme       Application 
 
Laundry 
Detergents 
 
Proteinase    
 
 
Used in pre-soaks to remove protein -
based stains.   
 
Lipase   
 
  
Now commonly included to digest oils 
and fats. 
 
Amylase  
 
  
Removes resistant starch residues.  
Cellulase  Digests the cotton “fuzz” which 
accumulates with excessive washing. 
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Table 1.1 (contd.) : The industrial application of enzymes [10].  
 
Starch 
Industry 
Amylases, amyloglucosidases  
and glucoamylases 
  
Converts starch to glucose and other 
sugar syrups. 
Glucose Isomerase Converts glucose syrups into fructose 
syrups. 
 
Dairy 
Industry 
Rennin from the stomachs of  
young ruminant animals 
Manufacture of cheese. 
 
Lipases 
 
Enhances ripening of blue-mold 
cheeses. 
 
Lactases Break down lactose to glucose and 
galactose. 
 
Textiles 
Industry 
 
Amylase 
 
Now widely used to remove starch 
from woven fabrics. Starch is used as 
an adhesive (or “size”) on the threads 
of many fabrics to prevent damage 
during weaving. Traditionally, 
chemicals were favoured but now 
bacterial  amylases are commonly 
used. 
 
Brewing 
Industry 
 
 
 
 
Amylases, glucanases, 
proteinases 
Splits polysaccharides and proteins in 
the malt 
 
Proteinases  
 
Reduces clouding of beers  
 
Amyloglucosidase 
 
Low calorie bee beer  
 
β-glucanase 
 
 
Improves filtration characteristics. 
 
Baking 
Industry 
 
α -amylase  
 
Catalyses the breakdown of starch in 
flours. Used in the manufacture of 
bread. 
 
β-xylanase Improves the characteristics and rising 
of bread.  
 
 Proteinases Reduces the protein in flour. Used in 
biscuit manufacture. 
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Table 1.1 (contd.) : The industrial application of enzymes [10].  
 
 
Leather 
Industry 
Proteinase (trypsin) The process known as “bating” treats 
the leather with proteinases to make it 
more pliable. Trypsin isolated from 
both slaughterhouses and micro-
organisms replaces the old method of 
using dog and pigeon faeces. 
 
Pulp and 
Paper 
Industry 
β-xylanases  Emerging technology for enhancing  
pulp-leaching 
 
Lipases Reduces “pitch” which causes paper to 
stick to rollers and tear. 
 
1.3 Protein Engineering for Ideal Biocatalysts  
Meeting the demand for the new products, which increasingly include newly 
developed and/or sterically pure pharmaceuticals and fine chemicals, has become an 
important incentive for the further development of biocatalysts technology. However, 
in many cases, naturally occurring biocatalysts lack features necessary for the 
application of interest, because they have evolved in nature to serve a purpose rather 
than the acceleration of industrial processes. There is usually a wide gap between 
what a biocatalyst found in nature is capable of catalyzing and what is required for a 
cost effective industrial process; since substrate specificity, substrate or product 
inhibition, enantioselectivity, rate of catalysis, pH optimum, and stability at elevated 
temperatures and in organic solvents, will be very specific for any desired reactions. 
The facilities of recombinant DNA technology and polymerase chain reaction (PCR) 
supplied the possibilities of the reorder a protein molecule on the nucleotide level by 
deletion or insertion of fragments, by random changes within defined regions, or by 
defined changes at specific sites. Recombinant DNA technology paved the way for 
protein engineering and for synthetic applications of enzymes found in nature. 
Protein engineering may be achieved by using the transcription, translation, 
transformation-expression ability of the microorganism, and recombinant DNA 
techniques and PCR being key technologies. 
A while later, in the middle 20
th
 century, to overcome these obstacles due to the 
properties of enzymes in found nature for application in industry, protein engineering 
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has emerged as a powerful and versatile means of tailoring biocatalysts in order to 
adapt their properties to the process requirements. Protein engineering which is 
described as practical uses ability of “Darwinian evolutionary engineer” based on 
recombinant DNA technology to construct biomolecules for industry has been 
developed.  
Darwinian evolutionary methods were introduced in protein engineering aiming to 
improve the properties of biocatalysts with enhanced efficiency, thermal stability, 
tolerance to organic solvents and other demands by in vitro techniques. Clues as to 
how to engineer better biocatalysts, however, come from studying how nature has 
done it. Protein evolution shows that biocatalysts are highly adaptable molecules, at 
least over evolutionary time scales.  
The explosion of tools that has come out of protein engineering during the last 25 
years has made it possible for us to evolve biocatalysts for features never required in 
nature. The most effective type of the used method for overcoming these obstacles is 
the evolutionary methods which mimic the process of Darwinian evolution in the test 
tube by combining mutagenesis and recombination with selection or screening for 
improved variants with the desired characteristics [6-7]. The presence of protein 
engineering has provided biochemists in laboratory bench for the beginning of 
producing commercial bio-products especially biocatalysts with desired properties 
for pharmaceutical and agricultural industry. As key discipline catalysis, enabling 
clean and cost-efficient processes in chemistry for many varieties of different 
products has a strong economic importance in industry. To date, more than 500 
products over a wide spectrum of applications have been manufactured by “ideal” 
biocatalysts. Well-known examples are ephedrine, aspartame and amoxicillin. A 
large number of Nobel Prizes in catalysis show high innovation potential of catalysts. 
The latest prize, in 2010, was awarded jointly to Richard F. Heck, Ei-ichi Negishi, 
and Akira Suzuki for their supplements in organic synthesis by using catalysts [4-5]. 
1.3.1 Ideal biocatalysts for industrial applications 
The primary objectives are turnover, selectivity and molecular stability for any ideal 
designed of new biocatalysts. The turnover of an enzyme represents a high degree of 
substrate conversion to product in the minimum possible time. Although turnover is 
the key property for the enzymes, enzymes generally used in bioconversions vary 
7 
 
widely; high turnovers are the characteristics of most current commercial 
biocatalysts. Functional capacity of enzymes is determined by genetically and 
microenvironment of them which has been formulated and applied. 
Microenvironment of enzymes having influence over the maximum achievable 
turnover are temperature, substrate/product solubility, reagent stabilities, exclusion 
water, ions, solutes and the need to reduce undesirable side reactions [12]. 
Ideal biocatalysts having broad substrate selectivity are essential, as in the use of 
different industrial areas. Control and optimization of stereoselectivity in the 
synthetic biotransformation and chiral resolutions have been seminal focus areas in 
biocatalysts in recent years. Changing substrate selectivity has progressed to the 
point where the functionality of biocatalysts can be transformed from one reaction 
type to another [13]. 
Substrate selectivity can readily be altered, using molecular or reaction engineering 
methods, to the extent where compounds of very different steric structure and 
chemical nature from the natural substrates can be efficiently converted by the 
designed biocatalysts [14-15]. 
Molecular stability of biocatalysts is a major issue for all bioprocesses, as it affects 
process economics at a number of levels. Biocatalyst with poor stability results in 
longer process operations, increasing frequency of catalyst replacement and reducing 
product yields. The causes of reduced biocatalyst stability occur in extreme 
temperature values, ionic strength, pH or presence denaturants like 
substrates/products, organic solvents etc. [16-18]. 
In order to change properties of biocatalysts based on these key properties, protein 
engineering has developed some experimental approaches. These involve four steps: 
choosing the protein changes (random/rational design), making those changes called 
mutagenesis, and evaluating the protein variants for improved properties 
(screening/selection) and lastly characterization of the selected enzyme variants. 
1.4 Choosing the Best Protein Engineering Approaches and Methods 
Protein engineering is a key method to produce novel biocatalysts for 
biotechnological industries. Protein engineering has many points used in planning 
developed approach for engineering protein. By planning correct strategy of protein 
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engineering, oil recovery is enhanced; cellulosic ethanol is produced [19]. Under 
favor of selected right protein engineering approaches (Table1.2), proteases are used 
in detergent with bleach [20]. Polyester is produced by using well-engineered 
enzymes [21].  
Rational design and molecular evolution are main approaches for protein 
engineering. Rational design introduces mutation(s) to specific protein sites in 
enzyme for desired properties and requires structure-function relationship and 
structure information of the enzyme. However, molecular evolution does not need 
any structure, function of enzymes but randomly generated huge amount mutant 
enzymes need screening for targeted properties.  
Limitations of each approach should be considered to choose the best approach, such 
as information intensity (detailed structure-function info), methods for mutagenesis 
in rational design, tools of selection and screening in directed evolution. So, selecting 
different strategies can lead to different advantages or disadvantages. For example, 
there is a trade-off between the efforts devoted to rational design versus screening. 
At one extreme, rational design starting from X-ray crystal structures of a well-
understood enzyme can limit the screening effort to a few amino acid substitutions. 
At the other extreme, a powerful screening method can eliminate the rational design 
step completely [9]. Therefore, the choice of the best method is governed by 
choosing the best locations and how to introduce the substituted amino acids and also 
screening methods. 
While choosing the best location for amino acid substitution strategy in rational 
design, increasing the thermostability of protein is one common protein-engineering 
target. A more rigid enzyme can be obtained for high temperatures based on the 
several approaches including the usage of information from X-ray structure of the 
enzyme, designing specific stabilizing interactions like salt bridges/disulfide bonds,  
stabilizing the loop by inserting Pro/removing Gly, focusing mutagenesis where most 
flexible region of the target enzyme [9]. 
The enantioselectivity and catalytic activity of the enzymes may be improved by 
substituting the amino acid residues which are closely located on the catalytic site of 
the target protein [22]. 
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Error-prone PCR (epPCR), saturation mutagenesis for single amino acid substitution 
and gene synthesis to add specific changes, shuffling, and simultaneous mutagenesis 
of many sites for multiple amino acid substitution are widely used strategies for 
introducing amino acid substitution [23]. A single amino acid substitution leads to 
increased enantioselectivity of nitrilase and amine oxidase [24-25]. A variant of 
nitrilase having only Ala190His substitution is the unique reason of increasing 
enantioselectivity toward an intermediate for the synthesis of atorvastatin [25]. 
Creating multiple amino acid substitutions in target protein gives extra choices and 
possibilities but leads to miss any cooperative interactions and creates a big library 
having many inactive variants.  
In order to remove cooperative interaction of multiple amino acid substitutions, F. H. 
Arnold suggested the stepwise accumulation of single amino acid substitution that 
each step having a variant is better than the previous one [26]. For finding the paths 
to the final particular variant of target protein having desired properties, all possible 
paths should be tested. For amino acid substitutions at five positions, there are 120 
possible paths to the final particular variant. Resistance of β-lactamase was improved 
with 18 paths at each stage [27]. Enhancement of the thermal stability of the enzyme 
phytase was done. After 9 rounds of optimization, the Tyr277Asp mutation was the 
only one that resulted from a single base exchange; the other was double-base (three 
mutations) and three-base exchanges [28].  
The previous mutation before the final particular variant can lead to a dead end. 
Random mutations at several sites avoid this possibility of new mutants and can 
result in a dead end. Nevertheless, mutation at several sites cost much more 
screening. Before screening these huge numbers of variant libraries, a selection 
method can be applied to decrease the number of variants that will be screened [29]. 
Another way for the reduction of the screening step is to eliminate unfolded or 
unstable proteins by doing some assumptions [30-31]. 
With small data sets, it is possible to discern which mutations are beneficial for a 
given trait, by manual manipulation of the data. However, as more mutations are 
evaluated in a given library, and each library is screened for a variety of traits, the 
data set becomes too large analyze by hand. ProSar is a statistical way and has no 
counterpart in biological evolution for protein structure-activity relationship. ProSar 
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compares all the data for each variant having the same substitution so it gives an idea 
about that substitution whether it is functional or not [32-33].  G. W. Fox used 
ProSar successfully for the evolution of a halohydrin dehalogenase [34]. 
There are many screening strategies. Most of them are time consuming and need 
hard work. Sometimes, because of the lack of a suitable screening-selection strategy, 
final particular variant or the best solution can be missed. However, there are some 
limited colorimetric screening strategies that have been developed for a limited 
number of enzymes.  
The best protein engineering approach can be defined as one that brings the best 
solution with the least effort in a short time. Therefore, because of the lack of 
suitable screening method for all industrial enzymes in directed evolution and 
difficulty of hitting the best substitution for the desired functions of enzymes in 
rational design, both of them cannot be unique approaches for protein engineering. A 
combination of both strategies represented the new route to improve the properties 
and function of the enzymes and made more rapid progress in protein engineering.  
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Table 1.2 : Examples of some technologies available for enhancing biocatalyst characteristics
 
[11]. 
 
Target improvement           Technology available              Example          Activity enhancement 
Increased turnover           Solubilization of enzyme           Solubilization of subtilisin             Specificity constant kcat/KM of  
   (using isooctane + aerosol OT)         solubilized subtilisin in octane =10
3
× 
                    for application in organic   that of suspended enzyme, and 0.1× 
                    solvents    that in aqueous medium; stability in   
             octane 10
3 
× > in aqueous medium. 
            
  Biocatalyst plastics using   Incorporation of chymotrypsin and  
chymot rypsin and subtilisin  susbtilisin in synthetic polymers gave     
    10
4 
×increased reaction rates with                                 
    high stability, in polar solvents,                  
    facilitating efficient peptide synthesis. 
 
Solubilization chymotrypsin     Activity subtilisin Carlsberg 10
3
 greater                                                                                            
and subtilisin for use in organic than freeze-dried powder and                
solvents using propanol          comparable with, 
rinsing treatment    crosslinked enzyme crystal preparation. 
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Table 1.2 (contd.) : Examples of some technologies available for enhancing biocatalyst characteristics
 
[11]. 
 
 
Altered      Directed evolution  Improved enantioselectivity  Pseudomonas aeruginosa lipase  
enantioselectivity         in lipases               activity with improved S- 
                        enantioselectivity; 2% ee increased 
                       to 81% ee after four generations of 
                        mutants. 
 
        Reversed hydantoinase                      Conversion of  D- to L- selectivity 
        enantioselectivity             with fivefold increase in total activity, in 
                                                                                                                                                         Arthrobacter sp. hydantoinase used for 
                                                                                                                                                         production of L-methionine. No natural  
                                                                                                                                                         L-specific  hydantoinase is known. 
 
        Improved enantioselectivity            Mutant esterases from Pseudomonas  
        in esterase-catalysed                    fluorescens to hydrolyze bulky 
selective resolution             giving 25% ee 
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Table 1.2 (contd.) : Examples of some technologies available for enhancing biocatalyst characteristics
 
[11]. 
 
Altered functionality Rational design and   New isomerase activity             Conversion of indole-3-glycerol  
    directed evolution   evolved              phosphate synthase into E.coli  
               phosphoribosylanthranilate 
               isomerase with 2×lower kcat 15× 
               lower KM than the native enzyme.  
 
                      Rational Design             Desaturase altered to            Change of activity from double-bond  
hydroxylase insertion to hydroxylase hydroxylation in  
oleate desaturase, by site-directed   
mutagenesis at seven sites, selected by 
comparative analysis of amino acid 
sequences of oleate desaturases and 
unrelated hydroxylases. 
 
Gene shuffling and  Modified β- galactosidase             DNA shuffling gave an evolved  
Screening   activity              β- galactosidase  with 10-fold 
                   increased fucosidase and 40- 
                                                                                                                          fold less galactosidase activity  
    due to six amino acid changes. 
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Table 1.2 (contd.) : Examples of some technologies available for enhancing biocatalyst characteristics
 
[11]. 
 
Conversion of non-   Directed evolution  Recombination to   Genes for biphenyl oxygenase  
natural substrates    specificity   alter substrate    activity from Pseudomonas  
 pseudoalcaligenes and 
             Burkholderia cepacia, with different                                     
         substrate specificities, recombined 
         to give dioxygenase activity for  
         efficient PCB conversion. 
 
Increased enzyme     Directed evolution   Thermostable esterase  Improved thermostability (> 14
o
C  
stability       developed by directed   increase in Tm after six cycles of  
        evolution    mutation) without loss of  activity, 
             showing that the two properties are  
             not mutually exclusive. 
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Table 1.2 (contd.) : Examples of some technologies available for enhancing biocatalyst characteristics [11]. 
 
                                                                                                Increased thermostability            Subtilisin was altered by eight amino  
      of subtilisin E              acid susbstitutions, to give functional 
thermitase using PCR mutagenesis and 
staggered extension process 
recombination. 
 
 Genetic and rational  Increased thermostability            Protease activity with half-life 170 
approach    in a protease              min at 100
o
C, in the presence of  
denaturants, and wild-type level of 
activity, in eightfold mutant of 
thermolysin-like protease from Bacillus 
stearothermophilus. 
 
Modified reaction   Directed evolution   Increased esterase activity in             p-Nitrobenzyl esterase activity of  
milieu                   Aqueous/organic medium            subtilisin in 30% DMF increased 50× 
                                                                                                                                                           using random mutagnesis. 
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1.5 Recent Developments in Protein Engineering Approaches 
Combinatorial active site saturation test (CAST) is a new structure based method 
compromise between conventional saturation mutagenesis at single sites and 
simultaneous randomization at multiple sites in protein engineering was developed 
by Reetz et al. [35]. The CAST has the great advantage over other strategies in that 
the number of clones that have to be screened is comparatively low. It has already 
been successfully applied to a number of biotechnologically relevant enzymes (Table 
1.2) for substrate acceptance, enantioselectivity, and thermal stability and proved to 
be a promising alternative to the previous methods. 
CAST has been first applied to a lipase from Psedomanas aeruginosa to increase the 
substrate specificity of the enzyme. The mutant protein showed a catalytic activity to 
the selected new substrates 10
3
 more than wild-type lipase. CAST pays a particular 
attention to complete randomization of pairs of possible synergetic amino acids 
(targeting more than one amino acid as a set like directed evolution strategies) that 
are positioned close to each other near or within the active site and point in the 
direction of the substrate binding site (Fig.1.1). Such an approach requires at least 
structure of the corresponding model or information of the three-dimensional 
structure of the respective enzyme like in rational design. Therefore, it is a 
combination of rational design and directed evolution approach in protein 
engineering [35]. 
 
Figure 1.1 : An example of CAST technique having A, B, C library consisting of at 
                    least 2 amino acids for a few rounds. Selected candidate amino acids of  
                    each library changes in the each cycle of CAST. 
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CAST has been applied to the epoxide hydrolase from Aspergillus niger for 
improving enantioselectivity [36]. The experiments led to an improvement in the 
selectivity of factor E from 4.5 for wild-type to 114 for mutant Aspergillus niger 
epoxide hydrolase.  
One most important property is the thermal stability of enzymes targeted by CAST in 
Reetz et al. experiments [37]. The final variant of mesophilic lipase from Bacillus 
subtilis shows more than 80 residual activities, however, the wild type does not have 
any activities over 70
o
C. Most of the exchanged amino acids are positioned that is 
not common places for exchange amino acids in thermal stability studies. 
CAST needs three-dimensional (3D) information of enzymes for selecting 
appropriate codon for randomization, so 3D protein structures are of great interest for 
the CAST of many different types of biological experiments. In the absence of 
experimental three-dimensional structures of the enzymes of interested homology 
modeling of enzyme to plan and analyze biological experiments provides important 
3D information about them. 
1.6 Homology Modeling 
Currently, there are about 20000 experimental protein structures collected in the 
Protein Data Bank (PDB) [38]. However, the number of sequence entries in 
databases is about 850 000. That means no structural information is available for the 
vast majority of protein sequences. The gap between the size of the protein sequence 
data and protein structure data is large and has been increasing. 
Even several important developments have been made in the field of experimental 
structure detection methods by X-ray crystallography and nuclear magnetic 
resonance spectroscopy (NMR) both experimental methods are very costly and time-
consuming processes and  without guaranteed success.  
Therefore, the computational methods for protein structure prediction have gained 
much more interest in recent years. Homology or comparative modeling is a method 
of predicting the 3D structure of enzymes and the only method that can reliably 
generate a 3D model of a protein (target) from its amino acid sequence among all 
current theoretical approaches. It has been applied in late 1970’s using early 
computer imaging methods by Tom Blundell [39-40]. It covers four steps: searching 
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databanks for the structural homology, alignment template band target, constructing 
a model and optimization and the last step is model quality evaluation [39-40]. 
For successful model building, correct folding (similarity between template and 
target), model coverage (at least one experimentally solved 3D structure of template), 
C - deviation (root mean square deviation-rmsd- between target and template), 
alignment accuracy (a significant amino acid sequence similarity between target and 
template), and placement (optimized placement for template side chains) should care 
during applied homology protocol.   
There are various structural genomics initiatives aiming to speed up the elucidation 
of new protein structures [41]. Experimental structure elucidation and comparative 
modeling complement is another one in the exploration of the protein structure space. 
A key to the efficient coverage will be the careful and optimal selection of the 
proteins for structural genomics [42]. The growing number of structural templates 
brings a steadily increasing number of sequences into ‘modeling distance’ for 
comparative modeling.  
Modeling of protein structures usually requires extensive expertise in structural 
biology and the use of highly specialized computer programs for each of the 
individual steps of the modeling process. When a model structure of a template 
protein molecule is constructed, this candidate model requires minimum potential 
energy that means stability or acceptable state of the template protein model. The 
requirement of “polishing and shining” is called as energy minimization. In this step, 
the potential energy function is minimized by searching for the minimum of this 
function which corresponds to the optimum geometry of the model. 25–50 steps 
energy minimization removes atomic overlaps and unnatural strains in the obtained 
homolog model, stabilizes or reinforces strong hydrogen bonds, breaks weak ones, 
brings protein to lowest energy in about 1-2 minutes central processing unit (CPU) 
time [39]. 
In spite of special care, every model obtained from homology modeling contains 
errors because of two reasons; one is % sequence identity between reference and 
model and another is the number of errors in templates. Hence, it is essential to check 
the correctness of overall fold/structure, errors of localized regions and 
stereochemical parameters: bond lengths, angles, geometries. Improvements may 
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include simultaneous optimization techniques in side chain modeling and loop 
modeling or developing better optimizers and potential function, which can lead the 
model structure away from template towards the correct structure. 
1.7 Molecular Dynamic Modeling 
Macroscopic properties are often determined by molecule-level behavior. 
Quantitative and/or qualitative information about macroscopic behavior of 
macromolecules can be obtained from simulation of a system at the atomistic level.  
Molecular dynamics (MD) simulations calculate the motion of the atoms in a 
molecular assembly using Newtonian dynamics to determine the net force and 
acceleration experienced by each atom. Each atom i at position ri, is treated as a 
point with a mass mi and a fixed charge qi. 
Steps in molecular dynamics simulations are building realistic atomistic model of the 
system, simulating the behavior of your system over time using specific conditions 
(temperature, pressure, volume, etc.) and analyzing the results obtained from MD 
and relating to macroscopic level properties. 
Forcefield, preparing a realistic atomistic model of system and determining specific 
conditions (temperature, pressure, volume, etc.) will be used in MD is needed for 
molecular dynamics simulation. 
In molecular dynamics, a molecule is described as a series of charged points (atoms) 
linked by springs (bonds). To describe the time evolution of bond lengths, bond 
angles and torsions, also the non-bond van der Waals and elecrostatic interactions 
between atoms, one uses a forcefield. The forcefield is a collection of equations and 
associated constants designed to reproduce molecular geometry and selected 
properties of tested structures. One common used forcefield is CHARMm forcefield. 
Energy terms and function described in the CHARMm forcefield is defined as (1.1) 
[43];  
18 
 
                         
Ubond = oscillations about the equilibrium bond length 
Uangle = oscillations of 3 atoms about an equilibrium angle 
Udihedral = torsional rotation of 4 atoms about a central bond 
Unonbond = non-bonded energy terms (electrostatics and Lenard-Jones) 
Preparing a realistic atomistic model of system includes collecting knowledge related 
to assigned atom types to identify different elements and different molecular orbital 
environments, assigned charges to each atom and connectivity between atoms in 
topology files. Another file is the parameter file having information about force 
constants is necessary to describe the bond energy, angle energy, torsion energy, 
nonbonded interactions (van der Waals and electrostatics), and suggested parameters 
for setting up the energy calculations. 
A capable of reading and manipulating this information like X-PLOR, CHARMm, 
NAMD2, AMBER, GROMOS, EGO, PROTOMOL, etc. are needed.   
Minimize the energy of the system in order to reach the most favorable configuration 
is essential in preparing the system for MD energy minimization. The energy of the 
system can be calculated using the forcefield. The conformation of the system can be 
altered to find lower energy conformations through a process called minimization. 
The most common minimization algorithms are steepest descent, conjugate gradient, 
BFGS (quasi-newton variable metric method) and Newton-Raphson algorithm.  
Steepest descent algorithm slowly converges and is used for highly restrained 
systems. Conjugate gradients are efficient, using intelligent choices of search 
direction for large systems. Newton-Raphson algorithm calculates both slope of 
energy and rate of change. 
Biological activity is the result of interactions between molecules and occurs at the 
interfaces between molecules (protein-protein, protein-DNA, protein-solvent, DNA-
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solvent, etc.). Therefore, creating water box or shell to enclose the molecule is 
critical for MD. A model solvation is needed for many biological processes occurring 
in aqueous solution, solvation effects playing a crucial role in determining molecular 
conformation, electronic properties, binding energies, etc.  For model solvation, 
solvent molecules are added to the molecular system or solvent is modeled as a 
continuum dielectric called explicit treatment and implicit treatment respectively. 
MD is defined as changing in conformation over time using a forcefield. MD uses 
energy function (1.2): 
                 (1.2) 
For determining the force on each atom, this equation is used (1.3): 
                (1.3) 
Newton’s equation represents a set of N second order differential equations which 
are solved numerically at discrete time steps to determine the trajectory of each atom 
(1.4): 
             (1.4) 
Based on these equations, several MD ensembles are constructed.  Some of them are 
constant energy-number of particles (NE), constant energy-volume (NVE), constant 
temperature-volume (NVT), and constant temperature-pressure (NPT) [44].   
By using the best fits prepared system, simulation can be performed for a system of a 
few tenths of angstroms on the length scale and for a few nanoseconds on the time 
scale. 
Initial velocities are assigned at a low temperature for the system. Periodically, new 
velocities are assigned at a slightly higher temperature and the simulation is allowed 
to continue. This is repeated until the desired temperature is reached. After running 
the simulation, the structure, pressure, temperature and energy become stable with 
respect to time, which is a point of the equilibration phase.   
In analyzing the simulation results, mean energy of structure and root mean square 
(RMS) difference between two structures are cared and final optimized structure is 
visualized with molecular graphics programs. 
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1.8 Bacillus Stearothermophilus L-Lactate Dehydrogenase (bsLDH) 
The reaction in the pyruvate to lactate direction is achieved by reducing a carbonyl 
group of the oxo-acid substrate with a hydride ion donated by NADH (used as a 
coenzyme) and a proton from the protein. The disadvantages of LDHs are their 
inhibition of by excess substrate (pyruvate) and also not having very broad substrate 
specificity. 
LDH catalyses the interconversion of pyruvate (oxo acid) and lactate (hydroxy acid) 
using the NADH/NAD+ pair as a redox cofactor [45]. The chirally pure α-hydroxy 
acids, derived from the reduction of the corresponding achiral α-oxo acids, are used 
to produce various pharmaceuticals such as semi-synthetic penicillin (using S-α-
hydroxyisocaproic acid) and antihypertensives (using S-α-hydroxyl-4-phenyl 
butanoate). They are also used in medicine to diagnose phenyl ketonuria by detecting 
S-ketoisohexanoic acid. LDH enzymes have been isolated from many species. 
Among these, the NAD+- dependent lactate dehydrogenase (LDH) enzyme from 
Bacillus stearothermophilus has been the subject of intensive research of its structure 
and catalytic properties. This has been prompted by its industrial potential in the 
production of chirally pure hydroxyl compounds. The production of chiral (S) α-
hydroxyacids is now at the 10-ton scale in industry and any development facilitating 
the reduction of pyruvate at concentrations greater than 0.1 M would be profitable. 
bsLDH was cloned and overproduced to analyze in details [46].  
After the sequence of bsLDH was determined, the first analyzing study in the level of 
amino acid was done for Arg171 in 1987 [47]. Arg171 residue of bsLDH, in the 
active site of the enzyme, interacts with carboxylate group of an α-keto acid by using 
its guanidium group, that is of basic importance in orienting the substrate for 
productive substrate-enzyme complex. Arg171 was changed with Lys by using site-
directed mutagenesis. This replacement does not have any effects on coenzyme 
binding and a small effect on the kcat whereas 2000-fold increase in the KM of the 
enzyme. This result is explained with the small increase in the distance of Lys-
carboxylate of substrate interaction at this part and the lack of the extra hydrogen 
bond that occurs in carboxylate of substrate-Arg171 of the wild type enzyme. 
Holbrook and his colleagues [48] focused on Arg171 at the substrate-binding site of 
bsLDH and changed it with Lys. They observed that this change resulted loosing of a 
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strong carboxylate-guanidium interaction in the mutant and this mutation decreased 
the binding energy of substrate (pyruvate, α-ketobutyrate etc.) However, there is a 
loss of about 1.5 kcal/mol of binding energy for each additional methylene group on 
the substrate in both mutant and native enzymes. They concluded that the way of the 
binding productive substrate is the same in both enzymes. While substrate size 
increases, KM increases in the wild type but decreases in mutant bsLDH. Because of 
the Arg171, probability of substrates binding in terms of productive substrate 
enzyme complexes increase in wild type but not in mutant bsLDH enzyme. 
Another group from Canada changed Arg171 with hydrophobic Tyr and Trp to broad 
substrate (R=Me, Et, n-Pr, n-Bu, and CH2OH) specificity of bsLDH [49]. Although 
kcat/KM of mutant enzyme is lower than wild type enzyme, is more active than the 
previous mutant (Arg171Lys) which is designed by K.W. Hart. Their one important 
result is that, losing the Arg171 has no effect on giving optically pure L-lactate by 
reducing pyruvate catalyzed by Trp171 and the another  is secondary polar or 
hydrogen bonding associations of Arg109 and Thr246 that attributed the retention of 
L-stereospecificty with the substrate COO-function is major determinant of   
maintaining substrate orientation. 
Introducing oxaloacetate as a substrate to bsLDH is the first study about changing the 
substrate specificity of bsLDH. They designed bsLDH in order to change preferred 
substrates from the pyruvate/lactate pair (R=CH3) to the oxaloacetate/malate pair 
(R=CH2-COO), the volume of the active site was increased with Thr246Gly, an acid 
was neutralized with Asp197Asn and a base was introduced Gln102Arg. The triple 
mutant has a catalytic specificity for oxaloacetate over pyruvate of 500, whereas 
native of bsLDH has 1000 [50]. 
For the same purpose, another attempt was performed by J.J. Holbrook and his 
colleagues, because previous results (KM and kcat of mutant bsLDH for oxaloacetate) 
were not satisfactory while compared to native malate dehydrogenase (MDH) from 
different sources. Therefore, J. J. Holbrook redesigned bsLDH framework for a 
specific, highly active MDH [51]. The double mutant (Thr246Gly, Gln102Arg) was 
designed but only one mutant (Gln102Arg) showed an effective and highly specific 
catalyst for oxaloacetate over pyruvate. KM of mutant enzyme for oxaloacetate is 
equal to KM of native bsLDH for pyruvate and kcat of the mutant enzyme is double 
for MDH from the same organisms of the native bsLDH. 
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In 1989, A. R. Clarke and J. J. Holbrook published an article [52]. They described 
new attempts to design new enzyme recognizing a –CH2-COO- side chain instead of 
the –CH3 side chain recognized by the naturally evolved enzyme. It was seen that 
manipulating enzymes for the new substrates is reasonably hopeful, because useful 
products would be cheaply available from the redesign of natural enzymes. The 
designs of bsLDH were done for large hydrophobic substrate side chains. Although 
not involved in the catalytic site of enzyme two regions of the bsLDH were changed 
(102-105GlnLysPro-MetValSer and 236-237AlaAla-GlyGly) to increase the 
tolerance for large hydrophobic substrate side chains(R=CH3, C2H5 etc.). The five 
changes in bsLDH showed broad substrate specificity with a 55-fold improved kcat 
for α-ketoisocaproate [53].  
Designing new enzymes based on the LDH framework has been advanced as far as 
computational possibilities to be used in the modeling studies of enzymes. Map of 
the catalytic pathway was drawn for analyzing of the mechanism and structure of 
LDH [54]. 
A new phenyllactate deydrogenase was produced by peptide loop exchange on the 
bsLDH framework [55]. The mobile surface loop of polypeptide (residues 98-110) 
was sufficient for magnitude of substrate specificity. The loops with oligonucleotide 
overlap extension changed the variable length and sequence loops to produce 
hydroxyacid dehydrogenase. With one longer loop construction activity against 
phenylpyruvate was largely unaltered (kcat/KM=39000 fold).The selectivity of this 
new construct is enough to monitore phenylpyruvate in the urine of patients. 
Importance of the Thr246 at the active site of the bsLDH was tested by site-directed 
mutagenesis to Val, Ala, Leu, and Ser [56].  Effects of these mutants were tested 
even with different substrates. There is no major change in KM and kcat but Thr246 
can make it easy to transfer hydride from the nicotinamide ring of the NADH 
cofactor to the carbonyl group of the pyruvate. 
Substitutions of the amino acid Gln102 of the bsLDH with polar and aromatic 
residues affect substrate specificity [57]. Gln102 was exchanged with Ser, Thr, Tyr, 
and Phe to understand the effect of this substitution on substrate recognition. Because 
of the size of Ser and Thr, Gln102Ser and Gln102Thr mutant enzymes have a 
broader specificity for α-keto acids. While Gln102Phe, Gln102Tyr have no catalytic 
efficiency and substrate specificity, all enzymes have a little activity against 
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branched chain aliphatic substrates. This investigation showed that substrate 
discrimination depends on size discrimination. 
For omega-amino- α-keto acid substrates, having side chain ammonium groups 
Gln102 of the bsLDH was replaced with Glu and Asp acid amino acids [58]. When 
results are compared to native bsLDH, these mutants have 25-fold improvements in 
kcat/KM for omega-amino- α-keto acid substrates. 
The first broad library based on amino acid residues at position 101 and 102 with site 
directed mutagenesis for bsLDH was done by El Hawrani [59]. They selected some 
α-keto acids as a substrate (malate, phenyllactate etc.).  Asn101Val102 mutant 
enzyme has a good catalytic activity to phenylpyruvate. At the same time when the 
position 102 changed with Arg, obtained mutant is as active as many MDHs. 
Obtained mutants show kinetic rate well for each selected target than designed 
bsLDHs before. Even in the absence fructose-1,6-bis phosphate (FBP) for 
phenylpyruvate, Asn 101Val102 mutant enzyme has a notable activity. 
The first directed evolution of bsLDH was done by Stuart J. Allen [60]. The target of 
the directed evolution was to obtain a mutant working without FBP, because FBP is 
expensive and representative cofactor is undesirable in industry. After three rounds 
of directed evolution, obtained mutant (Arg118Cys, Glu203Leu, and Asp307Ser) had 
70-fold activation. The big surprise is none of the mutations were near the active site. 
The mutation Asp38Glu (previously named Asp52Glu in the LDH from B. 
stearothermophilus reduces the substrate inhibition by approximately two fold. The 
referred work [61] demonstrates that the designed mutant would weaken the cofactor 
binding to relieve substrate inhibition. 
To introduce mandelic acid as a substrate to LDH was implemented by redesigning 
Saccharomyces cerevisiae falvocytochrome b2: LDH [62]. Using protein 
engineering, a specific mandelate dehydrogenase was designed based on LDH 
framework. Two mutants (Ala198Gly, Leu230Ala) were designed and the mutant 
enzyme showed a 400-fold improvement on changing the substrate specificity from 
pyruvate to mandelic acid.  
Purification of individual enzymes is a time consuming and costly process. The 
common purification method of bsLDH has many steps, namely lysis, precipitation, 
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dialysis, chromatography etc. During all these steps wild type and mutant bsLDH 
enzymes may lose their ability to produce product and affinity to bind substrate 
Therefore, decreasing the production cost and improving the yield of purified 
enzymes are important. Production of target proteins using recombinant E. coli 
strains has some advantages compared with the systems based on wild strains. 
Recombinant systems could be employed for the production of different mutant 
LDHs with desired properties and large scale production with reduced cost by using 
protein engineering technology. 
TAGZyme purification system is a separation technique that uses covalently bound 
chelating compounds on solid chromatographic supports to entrap metal ions, which 
serve as affinity ligands for various proteins making use of coordinative binding of 
some amino acid residues exposed on the surface. The introduction of immobilized 
metal ion affinity chromatography, directed toward specific protein side chains has 
opened a new dimension in protein purification. TAGZyme purification system 
offers all possibilities for large–scale purification of many industrial enzymes as well 
as proteins for research in genetics, molecular biology and biochemistry. The 
introduction of (poly) histidine tags to the N- or C-termini of proteins via genetic 
manipulation has greatly simplified enzymes purification through affinity 
chromatography on metal chelate columns [63]. 
1.9 Phenylalanine Ammonia Lyase from Rhodotorula graminis 
Phenylalanine ammonia-lyase (PAL) catalyses the non-oxidative conversion of L-
phenylalanine (L-Phe) to trans-cinnamic acid (t-CA).  
 
 
Figure 1.2 : PAL enzyme catalyses the conversion of phenylalanine to trans- 
                     cinnamic acid. 
Purified PAL from various sources has a molecular mass in the range of 270-330 
kDa [64]. The enzyme is tetrameric with identical subunits. Pairs of monomers form 
a protomer with a single active site. It has been reported that potato tuber PAL is 
glycosylated and that mannose residues occur on an N-linked oligosaccharide side 
chain [65].  
25 
 
The first three-dimensional structure of phenylalanine ammonia lyase (PAL) has 
been determined at 2.1 Å resolutions for PAL from Rhodosporidium toruloides. The 
enzyme PAL has about additional 160 residues extending from the common fold of 
histidine ammonia lyase. It is believed that catalysis is potentially governed by dipole 
moments of seven R helices associated with the PAL active site (six positive poles 
and one negative pole).   
Interaction between the amino group of phenylalanine and conserved residues of 5-
methylene-3,5-dihydroimidazol-4-one (MIO) :12 methylidene group in N termini of 
helices was observed in the docking studies for active site of the PAL with 
phenylalanine. The conserved residues have important roles in activation of MIO, 
leaving out of product, activation of C3 by polarizing electrons from the phenyl ring 
of substrate and for recognizing substrate. His is close to C terminus of the helix. 
This position directs negative pole through the catalytic area causing an increase in 
the His`s basicity. So highly conserved His residue in N termini of helices behaves as 
general base. This basicity of the residue functions to abstract the pro-S hydrogen 
from C3 of substrate [66]. 
Observed dehydroalanine moiety in the active site of the enzyme gets together with 
the α-amino group of the substrate during “ordered uni-bi” in the catalytic reaction. 
In this catalytic reaction, firstly cinnamic acid then ammonium ions are released [67]. 
Due to having a catalytically important electrophilic group, the presence of 
dehydroalanine was believed for 30 years but has now been revealed by X-ray 
crystallography and UV spectroscopy to be a highly electrophilic MIO group. 
The electrophilic attack of MIO on the aromatic ring of the substrate that defined as 
an incomplete Friedel–Crafts type reaction causes to start the reaction observed in 
experimental studies. This reaction triggers the activation of a β-proton and its 
stereospecific abstraction. Finally, the elimination of ammonia and reproduction of 
the MIO group is observed. 
In order to detect essential amino acids for PAL, the exchange of Ser202 for Cys by 
site-directed mutagenesis was done. The effect of this exchange on the catalytic 
activity of PAL indicates that Ser202 is the precursor of the active site 
dehydroalanin. Further amino acids essential either for the post-translational 
modification or for catalysis, Arg174, Glu425, and Lys499 were changed to Ile.  
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Kinetic analyses for the heterologously expressed mutated genes showed that only 
the Arg174Ile has a serious decrease for Vmax [68]. 
Structure of histidine ammonia-lyase (HAL) that has been solved by X-ray 
crystallography has a homology with the plant enzyme phenylalanine ammonia-lyase 
(PAL, EC 4.3.1.5). In order to detect the substrate binding or catalytic residues in 
PAL; based on analysis of alignment of PAL and HAL, identical or similar Gln348, 
Ser203, Leu138, Phe400, Tyr110, Gln488, Tyr351, Asn260, and Arg354 residues 
have been mutated.    
Retey and his collogues see that in each case, mutagenesis diminished the activity of 
the kinetic constants of the over expressed and purified [69]. In the past three 
decades, PAL has gained considerable significance in several clinical, industrial, and 
biotechnological applications.  
Many successful industrial uses of PAL biocatalyst from Rhodotorula strains show 
that even PAL with its native substrate has a big industrial potential. Therefore, PAL 
has several commercial applications [70-72]. Despite the widespread distribution of 
PAL, Rhodotorula has been used exclusively for commercial purposes because of its 
high PAL levels and no fastidious requirements for growth and PAL synthesis [73-
74]. Rhodotorula PAL is effective in the treatment of certain mouse neoplasms [75], 
and used to quantitatively analyze serum L-Phe to monitor patients with 
phenylketonuria [70,63] and to prepare low phenylalanine diets [76]. Whole cells of 
Rhodotorula containing PAL have been used to synthesize L-Phe [74,76] and its 
methyl ester [70,77] by reversing the physiological reaction. 
PAL is specific for L-Phe, and to a lesser extent, L-Tyr. Other common L-amino 
acids are not deaminated; D-Phe and D-Tyr do not serve as substrates and are 
competitive inhibitors of PAL [78-79]. Recently, Calabrese et al. reported that PAL 
activities with L-Tyr were either low or undetectable for four PAL isoforms of 
Arabidopsis thaliana, thereby establishing L-Phe as the true physiological substrate 
[80]. However, the substrate specificity for PAL varies in different species. PAL 
from different sources has extraordinary properties. PAL from dicotyledonous plants 
has highly specific for L-Phe. PAL in photosynthetic bacteria has a major specificity 
for L-Tyr leads to produce p-hydroxycinnamic acid that is a chromophore for the 
photoactive yellow proteins [81].  
27 
 
In this study, we aimed to increase the activity of PAL from Rhodotorula graminis 
for the selected different substrate(s) by CASTing (Table 1.3) [82].  
PAL activity is determined by monitoring and measuring either the amount of L-Phe 
that has reacted or the t-cinnamic acid that is formed at the end of the enzyme 
reaction. Conventionally, the activity is calculated spectrophotometrically by 
measuring the absorbance of product, t-CA, at 290 nm [83].  
Recently, a liquid phase assay was developed for PAL activity by N.J. Turner group 
(unpublished).  This assay uses purified oxidase enzyme and is conducted in a 
microtiter plate reader. The advantage of this type of assay is that it can be used to 
quantify the activity of the oxidase enzyme and allow the measurement of the kinetic 
parameters of the reaction. 
It is important to use a soluble horseradish peroxidase (HRP) substrate for the liquid 
phase assay, as this assay is performed in a microliter plate reader and precipitation 
of the colorimetric product will result in a heterogenous mixture and incorrect data 
being obtained. In the liquid phase assay, several substrates for HRP can be used. 
These substrates include 4-aminoantipyrine with 3-hydroxy-2,4,6-tribromobenzoic 
acid, pyrogallol red, 2,2'-azinobis (3-ethylbenzthiazoline-6-sulphonic acid), and 
scopoletin. 
HRP oxidises 4-aminoantipyrine (4-AAP) in the presence of H2O2, which 
subsequently reacts with 3-hydroxy-2,4,6-tribromobenzoic acid (TBHBA) to form 
quinoneimine, the production of which can be detected at 510 nm in a 
spectrophotometer or microliter plate reader [84]. 
The stereoselective reaction of amino acid ammonia lyase that is addition of 
ammonia to achiral acrylic acid derivatives ends up amino acid. Phenylalanine 
ammonia lyase from Rhodotorula is a valuable industrial biocatalyst because of its 
native substrate. During catalyzing its own native substrate, PAL has high activity 
towards its natural substrate, stability under bioprocess conditions and tolerance of 
high concentrations of substrate and product without displaying significant 
inhibition.  
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Table 1.3 : The broad substrate range of PAL from Rhodotorula graminis[84]. 
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2. MATERIALS AND METHODS 
2.1 DNA Shuffling to Construct Shuffled Mutant bsLDH  
Bacterial strain E. coli JM105 {F′ traD36 proA+ proB+ laclq lacZΔM15/Δ (lac-pro) 
X111 thi rpsL (Strr) endA sbcB supE hsdR9} was used as a host to prepare all 
double-stranded DNA for mutagenesis and sequencing in the plasmid pKK223-3 
(Pharmacia Biotech, Uppsala, Sweden). The plasmid pKK223-3 is a transcription 
expression vector and contains a TAC promoter (Isopropyl β-D-1-
thiogalactopyranoside, (IPTG) inducible) which drives expression of recombinant 
genes and ribosomal termination sequences as well as ampicilin resistance [85]. The 
same E. coli strain was also used as a host for transformation and expression of 
bsLDH proteins in pKK223-3. 
The shuffled-bsLDH gene was constructed by the method used by Stemmer [86] 
with some modifications as explained below. When the method was applied to 
bsLDH it first involved isolating the coding DNA (an about 1 kb fragment) with a 5′ 
region containing an EcoRI site and a 3′ region with a PstI site. The product is of 
the correct size. About 10 μg plasmid containing wild type LDH gene was digested 
at 37 °C for 1 h with EcoRI and PstI in 20 μl 10 × digestion buffers. After 
purification from 0.8% agarose gel, 2 μg of the plasmid DNA of bsLDH was then 
randomly cleaved with the non-specific endo-DNAse I incubating the reaction 
mixture including 10 mM TrisHCl (pH 7.4), 10 mM of MnCl2 and 0.0015 U DNase 
I for 15 min at 20 °C. This should give a smear of randomly sized oligonucleotides 
smaller than 1 kb.  
Fragments with sizes 100–300 bp were purified from the corresponding region of a 
2.5 % agarose gel. These fragments were then amplified by PCR (94 °C for 30 s, 50 
°C for 30 s and 72 °C for 30 s) but without adding primers. This critical step 
generates sequence variation in the fragments generated in step 1. As expected, the 
products run on a gel as a characterless smear. The full-length gene is finally 
isolated by the second PCR (initial denaturation 96 °C for 2 min, 94 °C for 30 s,    
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55 °C for 30 s, 72 °C for 45 s, for 10 cycles and followed by another 14 cycles of  
94 °C for 30 s, 55 °C for 30 s, 72 °C for 45 s and final extension 72 °C for 12 min) 
step using the correct primers for the 5′ EcoRI (N-terminus) and 3′ PstI (C-terminus) 
sites and 4 μl of the first PCR product. A high yield of shuffled library about 1 kb 
bsLDH genes was randomly obtained on the gel. All PCRs were carried out in the 
presence of 0.2 mM of each dNTPs, 1× Taq buffer, and 2.5 U Taq/Pfu (1:1) enzyme 
mixtures [87]. The about 1 kb product was digested with EcoRI and PstI prior to 
cloning into similarly cut pKK223-3 DNA and the ligation products were used to 
transform E. coli JM105 competent cells. 
2.1.1 Screening for variants with substrate-specificity changes 
The screen was initially designed by A.S. El Hawrani for use with a thermophilic 
protein [59]. Having a thermophilic enzyme expressed in a mesophilic bacterial 
strain (E. coli JM105) allows inactivation of host proteins on the nitrocellulose filters 
using a heat step. The bsLDH library is blotted onto nitrocellulose filters and 
subjected to a number of steps. Lysis of E. coli cells on nitrocellulose filters was 
carried out and nitrocellulose filters were incubated at 65 °C [51]. 
The filters were incubated in the dark and any E. coli colonies expressing bsLDH 
protein with activity towards the hydroxy acid target substrate were detected by the 
appearance of a purple coloration around the edges of the bacterial colonies. Double-
stranded DNA of shuffled bsLDH having activity with oxaloacetate was sequenced 
to confirm the changes on the gene. Protein over-expression is conveniently 
established by the appearance of an intense band on an sodium dodecyl sulfate 
polyacrylamide gel polyacrylamide gel stained with coomassie blue dye. 
2.1.2 Construction of Gln102Arg -bsLDH 
Bacterial strains: Two different bacterial strains are used in this work, namely 
DH5α™-T1R competent cells ([F−ϕ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 
endA1 hsdR17(rk
−
, mk
+
) phoA supE44 thi-1 gyrA96 relA1 tonA]) which is supplied 
with Invitrogen™ GeneTailor ™ Site-Directed Mutagenesis System and JM105 as a 
host for transformation and expression of Gln102Arg mutant of bsLDH protein in 
pKK223-3. 
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The mutation was introduced into the bsLDH gene at required positions by site-
directed mutagenesis using Invitrogen Gene Tailor™ Site-Directed Mutagenesis 
System according to the manufacturer's protocol [88].  
The following oligonucleotides; 
Forward 5′GGTTGTCATTTGCGCCGGCGCCCGCCAAAAACCGG3′ 
Reverse 5′GGCGCCGGCGCAAATGACAACCAAATCGGCATC3′  
were used in order to construct the mutant gene. Base changes are shown in boldface 
on the mutagenic oligonucleotide primer. According to manufacturer's protocol, only 
one mutagenic oligonucleotide primer is required to generate a mutation site. The 
double-stranded DNA extracted from mutated bsLDH gene was sequenced in the 
region of the mutation to check for correct amino acid insertion. Purified DNA 
samples were sequenced using ABI Prism 3100-Avant automated sequencer at 
Molecular Biology and Genetics Dept, ITU. 
2.1.3 Molecular modeling 
Residue replacements and rotamer choices were performed using the molecular 
graphics and modelling software Accelrys Discovery Studio [89]. Likewise, 
oxaloacetate was modelled into the active site of shuffled-bsLDH by inspection. 
Energy minimisation of the oxaloacetate ternary complex in explicit water was 
performed using Discover 2.9.7 and the Cvff forcefield [89].  
2.1.4 Cell culture and protein purification 
The same protocols were used to purify both wild type enzyme and the mutant 
bsLDHs [90]. Fast protein liquid chromatography was used to purify the enzyme. 
The protein sample was loaded onto a blue-sepharose column, which had been 
washed with two column volumes of 100 mM of TrisHCl, pH 7.3. LDH was eluted 
by using a gradient from 0 M to 1 M NaCl in 100 mM of TrisHCl, pH 7.3. Sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and brilliant blue 
coomassie staining showed the proteins to be 98 % pure after the described 
purification. Finally, each enzyme was dialyzed against activated charcoal buffer to 
remove nucleotides. 
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2.1.5 Steady-state kinetics 
All kinetic parameters were measured in the absence and presence of 5 mM FBP, an 
enzyme activator at 25 °C in a reaction mixture containing 100 mM TrisHCl, pH 7.3, 
5 mM NADH, 5 nM enzyme and different concentrations of substrates; pyruvate, 
oxaloacetate and α-ketomalonate. Kinetic parameters were determined by observing 
the oxidation of the nicotinamide coenzymes at 340 nm in 10 mm, 1 ml quartz 
cuvettes mounted in a Perkin Elmer Instruments Lambda 25 UV/VIS spectrometer.  
2.2 Mandelic Acid As A Substrate For Highly Purified Bacillus 
Stearothermophilus Lactate Dehydrogenase 
2.2.1 General equipment and chemicals 
All chemicals were purchased from Sigma-Aldrich. JM105 competent E. coli cells, 
pQE-2 plasmid and 6xHis-tag protein purification system were purchased from 
QAIGEN. Gene Tailor site- directed mutagenesis system was purchased from 
Invitrogen and high pure plasmid isolation kit was purchased from Roche. All 
enzymes, unless otherwise mentioned, were purchased from Fermentas. Microfuge is 
from Beckman Coulter Microfuge. UV-Visible (Lambda 25) atomic absorption 
spectrophotometer is from Perkin Elmer Instruments. Microplate reader is Bio-Rad 
3550-UV and DNA sequences are analyzed in ABI Prism 3100-Avant automated 
sequencer from Applied Biosystems. 
2.2.2 Improving the purification of bsLDH   
The N-terminal histidine tag was introduced to clone the wild-type gene of bsLDH 
into the expression vector pQE-2 coding N-terminal fusion 6xHis-tag. Following the 
cloning strategy that is PstI_C-terminal and SacI_N-terminal primers were used in 
order to introduce new restriction enzyme sites, which are suitable for 6xHis-tag 
pQE-2 expression vector.  
Designed mutations were incorporated by an overlapping PCR method using 
complementary oligonucleotides. Primers were ordered from Eurofins MWG 
Operon. Primer sequences are listed in Table 2.1. The wild-type bsLDH gene in 
pKK223-3 was amplified according to standard PCR methods (94 °C for 5 min, 95°C 
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for 1.30 min, 50 °C for 1min, 72 °C for 2.5 min, 72°C for 10 min) in the presence of 
0.2 mM of each dNTPs, 0.8 pmol of each primer and 0.6 U Pfu DNA polymerase. 
Table 2.1 : The used primers for His-tag protocol system and site-directed 
                   mutagenesis of rationaly designed bsLDH. 
 
   Restriction sequences are underlined. 
 a
PstI and SacI recognition sequences (underlined) were added 
to the 5´and 3´ ends,  respectively, for the His-tag protocol. 
b
Nucleotide sequences conferring 
mutations are shown in lowercase. 
c
Reverse primers were designed to be used generally with 
mutation of same position. 
The amplified PCR product was cut with restriction enzymes SacI and PstI and 
ligated into similarly digested 6xHis-tag pQE-2 expression vector. Ligation product 
was transformed into E.coli JM105 and selected on Luria Broth (LB) Agar 
containing 100 µg/ml ampicillin. The final construction product double stranded 
DNA bases were sequenced on an ABI Prism 3100 sequencer according to the 
supplier's manual. All other cloning procedures and restriction enzyme digests were 
performed as described [91].   
The bacterial cultures harboring the desired plasmid were grown on a rotary shaker 
in LB supplemented with ampicillin (100 µg/ml). The bacterial cultures harboring 
the desired plasmid were grown on a rotary shaker in LB supplemented with 
ampicillin (100 µg/ml). 1mM of isopropyl-ß-D-thiogalactopyranoside (IPTG) was 
added when the optical density at 600 nm reached 0,6. 50 µl of sample was collected 
for determination of uninduce total protein expression. After growing overnight, the 
cells were harvested by centrifugation (15000 g, 2 min). The pelleted cells were 
stored at -80 ºC. 
The native enzyme was purified using nickel nitrilotriacetic acid (Ni-NTA) resin 
(supplied with kit) having 6xHis-tag protein affinity. The pelleted cells were kept at 
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37 ºC for 30 min and were suspended in 20 ml of lysis buffer containing 50 mM 
NaH2PO4, 300 mM NaCl, 10mM imidazole, pH to 8.0 with NaOH. Lysozyme (1 
mg/ml) was added and cell supension was incubated on ice for 30 min. 50 µl of 
sample was collected for determination of total protein expression from each step. 
Remaining cell suspension was centrifuged at 15000 g for 15 min at 4 ºC.  
Batches were prepared by pouring 2 ml of the 50 % Ni-NTA slurry into supernatant 
from the previous step in 20 ml falcons. The batches were incubated for 60 min on a 
rocking table at 4°C. 1ml washing buffer containing 50 mM NaH2PO4, 300 mM 
NaCl, 20 mM imidazole, 0.05% Tween 20, pH to 8.0 with NaOH was loaded to the  
resin four times to remove unbound proteins by centrifugation (13000 rpm, 1 min). 
Proteins of bsLDH bound to the metal groups of the resin surface were eluted four 
times with 1ml elution buffer containing 50 mM NaH2PO4, 300 mM NaCl, 250 mM 
imidazole, 0.05 % Tween 20, pH to 8.0 with NaOH by centrifugation (13000 rpm, 1 
min). The tubes were placed in a flask that contains distilled water with a high 
concentration charcoal for an overnight dialysis. The amount of obtained fractions 
from column for both tagged and untagged enzymes were calculated and compared 
with each other. 
2.2.3 Construction of mutated bsLDH protein  
Residue replacements and rotamer choices were performed using the molecular 
graphics and modeling software InsightII [89].  Likewise, L-mandelate was modeled 
into the active site of designed bsLDH by inspection. Energy minimization of the L-
mandelate binary complex in explicit water was performed using Discover Studio 
[89]. Site-directed mutagenesis using Gene Tailor Site-Directed Mutagenesis System 
was applied to construct Thr246Gly and Ile240Ala mutants of bsLDH according to 
the manufacturer’s protocol (Invitrogen). I240A_fw, I240A_rv, T246G_fw, 
T246G_rv primers (Table 2.1) are used for constructing Thr246Gly and Ile240Ala 
bsLDH mutants. Double stranded of plasmid DNA was isolated and methylated with 
DNA methylase. Methylated DNA was amplified with two overlapping primers to 
produce linear double stranded DNA. The PCR reaction (for I240A  at 94 
o
C for 2 
min initial denaturation, 94
 o
C for 5min, 95
 o
C for 1,30 min 50
 o
C for 1min, 72
 o
C for 
2,5 min 25 cycles, and at and 72
 o
C for 10 min final extension. For Thr246Gly at 94
 
o
C for 2 min initial denaturation, 94
 o
C for 30 sec, 50
 o
C for 30 sec, 60
 o
C for 30 sec, 
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68
 o
C for 5,5 min 20 cycles, and at and 68
 o
C for 10 min final extension) was carried 
out to obtain linear plasmid of bsLDH gene with the desired change on it in the 
presence of 0.3 mM of each dNTPs, 0.3 pmol of each primer and 0,02 U of 
PlatinumTaq High Fidelity polymerase. The mutagenesis mixture was transformed 
into DH5α-T1 cells (supplied by kit). The host cell circularizes the linear mutated 
DNA, and McrBC endonuclease in the host cell digests the methylated template 
DNA, leaving only unmethylated, and mutated product. The double-stranded DNA 
extracted from mutated bsLDH gene was sequenced in the region of the mutation to 
check for desired mutations. pQE-2 expression vector containing His-tag bsLDH 
gene was transformed into JM105 cells for over-expression bsLDH. 
The mutant enzyme was purified with Tagzyme purification system protocol which 
was mentioned for the native bsLDH before. The collected samples from each step 
were analyzed by SDS polyacrylamide gel (12 % w/v) electrophoresis. The native 
and mutant protein concentrations were determined by Bradford's method using 
bovine serum albumin as the standard [92]. 
2.2.4 Enzyme assay 
The wild type and mutant bsLDHs were kinetically analyzed in the presence of       
50 mM Tris.HCl pH 7.4 buffers as two sets at 25 °C. Steady-state reaction rates were 
determined by following change in A340 nm due to the formation and consumption 
NADH. Rate constant was analyzed using the non-linear least squares fitting 
program GraFit [93].  
2.3 Development of Novel Ammonia-Lyase Biocatalysts for the Production of 
Unnatural Amino Acids for Industry 
2.3.1 Optimization of screening method 
Primarily, to find an optimized screening method is so consequential. So we need 
calibration of the screens that will be used throughout this study. 
2.3.1.1 A pH sensing agarose plate assay 
pH indicators for compatibility in solid phase screening and selection of PAL activity 
were tried. Selecting the suitable medium is important in this assay. LB-Agar 
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medium including substrates, phenol red in 100 mM KH2PO4 was prepared. E.coli 
strains having recombinant PAL activity were streaked out. Then plates were kept 
overnight at 30 
o
C.  
2.3.1.2 The solid phase screen 
In this assay; minimal medium in the absence of NH4Cl plus phenylalanine was 
selected. PAL produces trans-cinnamic acid and ammonium by using phenylalanine. 
In the absence of NH4Cl, colonies consume ammonia as nitrogen source. Releasing 
trans-cinnamic acid makes a decrease on pH. To indicate pH changes phenol red 
added to medium. 
Another solid phase screen based on utilising the release of nitrogen due to 
enzymatic activity of PAL to support bacterial cell growth. The observed growth is 
because of nitrogen is being released, due to the activity of the PAL enzyme on the 
amino acid as a substrate. 
2.3.2 Constructing mutant PALs based on generating the CASTing libraries 
Through the use CASTing, it should be possible to obtain mutant PAL that accepts      
4-bromophenylalanine at greater rate than the wild type PAL enzyme. Select up to 5 
CASTing libraries – each library will consist of two residues that will be randomised 
using site directed mutagenesis. Previously generated 3D structure of PAL with 
homology modelling is used for selecting the residues that will make up the 
CASTing libraries [94]. All molecular modelling and in silico design of the CASTing 
libraries was conducted using Discovery Studio in InsightII [89]. 
2.3.2.1 Generation of saturation mutagenesis libraries with computational study  
Tyr369, Asn276, His143, Glu501, Arg372 are five (5) main candidate residues 
(Fig.2.1). A (His145, Gln146), B (Leu274, Asn278), C (Tyr371, Arg374),                 
D (Glu503, Asn506) are selected amino acids of CAST sites to be randomized 
simultaneously with the creation of relatively small libraries of mutants in terms of 
CASTing method. Last site is contact amino acids of PAL mer, E. Site E (Lys475, 
Ile479). The primers of 5 CAST sites for site-saturation mutagenesis in terms of 
CASTing method were designed.  
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Figure 2.1 : Showing the selected active site amino acids of the whole PAL and 
                     substrates with the distance (Å).  
 2.3.2.1.1 Primers 
NRT is selected as degenerative codon due to required low number mutant colony 
and coding desired amino acids. 
Table 2.2 : List of primers used for CASTing sites. 
 
In order to decrease the possibility of secondary structure, C base was changed with 
T base. (ggc:3.0 and ggt:2.8% ratio in E. coli). 
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First of all, pre-purified pET-16b PAL was transformed to XL-1 Blue chemically 
competent cells. The plasmid DNA in XL-1 Blue competent cells was purified using 
Qiagen QIAprep Miniprep Spin Kit, following the protocol provided.  
A QuickChange
®
 PCR reaction was carried out with pET-16b PAL as the template 
[95]. Reaction mixture having 7 µL template (100 ng), 1.5 µL forward primer        
(10 µM stock), 1.5 µL reverse primer (10 µM stock), 5 µL Pfu buffer (10x), 2 µL 
dNTP mix (10 mM each), 1 µL Pfu turbo, 5 µL DMSO and 11 µL H20. DNA for the 
saturation mutagenesis reactions using the primers, PCR conditions are detailed 
below. 
2.3.2.1.2 PCR program 
 
After the PCR the parental strand of DNA was digested with 1 µL of DpnI for          
3 hours at 37 °C, and then 1 µL of the digested PCR reaction mixture was used to 
transform XL-1 blue. 
For each library, ten colonies were collected for plasmid purification for sequencing.  
The rest of about 300 colonies for each library were lifted up by using 1 mL of LB 
Broth. Then plasmid purification protocol was applied to this 1mL LB Broth culture. 
BL21 (DE3) was used as host cell for transforming 1 µL purified plasmid library.  
After application of transformation protocol for BL21 (DE3), each library has about 
600 colonies. These colonies were picked and each one used to inoculate 800 µL of 
LB-amp in a deep-well 96-well plate for growing at 37 °C for overnight.  The cells 
harvested by centrifugation at 15000 rpm for 5 min.  The pellet was re-supended in 
50 µL of 16 % (w/v) glycerol.  After snap freezing of the pellet on liquid nitrogen, it 
was stored at -80 °C.  
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2.3.3 Screening of saturation mutagenesis libraries  
2.3.3.1 Growth  
Each glycerol stock of BL21 pET 16b PAL library A, D, E was inoculated to a 96-
well plate having 500 uL aliquots of LB-amp for growing at 37 °C for overnight.  
Then 20 µL of this each wells were inoculated to 48-well deep well plate having 2 
mL of LB-amp for growing at 26 °C for 18 hours. The cells were harvested by 
centrifugation at 15000 rpm for 5 minutes. 400 µL of 50 mM TrisHCl pH 8.8 was 
used for re-supending buffer of the cell. 
2.3.3.2 Assay  
The reaction was started by adding 100 µL of 20 mM L-4-bromophenylalanine to 
UV compatible 96-well microtiter plate having 90 µL of 50 mM TrisHCl pH 8.8, and 
10 µL of the whole cell supension from libraries and wild type PAL and monitor the 
conversion of L-4-bromophenylalanine to L-4-bromocinnamic acid at 290 nm for 1 
hour 30 minutes. The colonies have more activity than wild type PAL have prepared 
for sequencing. 
2.3.3.3 Purification of selected novel mutant PAL enzymes 
The native and mutant enzymes were purified using nickel nitrilotriacetic acid      
(Ni-NTA) resin [63] which the 6xHis affinity tag chelates to and can therefore be 
selectively removed from a mixture of proteins in solution. After growing overnight, 
the cells from library A and D were harvested by centrifugation
 
(15000 g, 5 min). 
The pelleted cells were stored at -80 ºC for overnight. Then the pelleted cells were 
kept at 37 ºC for 30 min for freeze thaw cell lysis.  The thawed cell pellets were 
supended in 20 mL of lysis buffer containing 50 mM NaH2PO4, 300 mM NaCl, 10 
mM imidazole, pH to 8.0 with NaOH. Lysozyme (1 mg/mL) was added and cell 
supension was incubated on ice for 30 min. The remaining cell supension was 
centrifuged at 15000 g for 15 min at 4ºC.  
Batches were prepared by pouring 2 mL of the 50 % Ni-NTA slurry into supernatant 
from the previous step in 15 mL falcons. A modified method of Qiaexpresionist by 
Qiagen was applied to mutant enzymes [63]. The batches were incubated for 60 min 
on a
 
rocking table at 4 °C. 1 mL washing buffer containing 50 mM NaH2PO4, 300 
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mM NaCl, 20 mM imidazole, pH to 8.0 with NaOH was loaded to the  resin seven 
times to remove unbound proteins by centrifugation (5000 rpm, 1 min). 
Proteins of PAL bound to
 
the metal groups of the resin surface were eluted three 
times with 1ml elution buffer containing 50 mM NaH2PO4, 300 mM NaCl, 250 mM 
imidazole, pH to 8.0 with NaOH by centrifugation (5000 rpm, 1 min). Purified 
protein was desalted by ultrafiltration and concentrated with 30000 molecular weight 
cut off (MWCO) of ultrafiltration membranes. The protein concentrations were 
determined by bicinchoninic acid (BCA) protein assay.  
2.3.4 Calculation specific activity of selected mutants of library 1 and 4 
5, 10, 20 µL enzyme diluted in variable 50 mM TrisHCl pH 8.8 buffer and incubated 
at 37 ºC 10 min. Start the reaction by adding then 25 µL 10 mM                               
L-4-Bromophenylalanine monitor the reaction for 1 hour 45 minutes at 290 nm. The 
specific activity of PAL was calculated using this assay, as 1 U equals 1 nmol of     
L-phenylalanine produced per minute. 
2.3.5 Enantioselectivity of the best mutant PAL 
The enantioselectivity of the best mutant PAL reaction was measured by only 
replacing AAO (amino acid oxidase) in both form D- and L-AAO. 
2.3.6 pH profile of the best mutant PAL  
The assay is carried out in TrisHCl buffer at pH 8, 8.5, 9, 9.5. The effect of different 
pH on the kinetic rate of conversion of trans-cinnamic acid and (NH4)2SO4 to          
L-phenylalanine was investigated for determining the optimum pH for the best 
mutant. 
2.3.7 Kinetics of the PAL reaction 
The standard curve for kinetic rate calculation was produced by adding known 
quantities of H2O2 along with HRP to a fixed concentration of scopoletin and 
observing the decrease in fluorescence. 
In order to grow E. coli cells having  pET 16b carrying the gene of mutants of PAL, 
plated from stock to 50 ml LB medium with ampicilin. After 18 hours at 37 °C, the 
culture transferred to 1 l LB medium with ampicilin for 18 hours at 26 °C. The 
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protein was purified the by using a modified method of Qiaexpresionist by Qiagen as 
before [63]. 
Enzyme assay was carried out in a UV compatible 96-well microtitre plate. Firstly, 
50 μL of 50 mM TrisHCl at pH 9, 10 μL of HRP (1 mg/mL), 10 μL of L-AAO (0.02 
units of enzyme), 40 μL of scopoletin, native and selected the best 4 PAL mutants 
were added into the wells. Finally, the reaction was commenced by adding various 
concentrations of different substrate(s). The solution contains 100 mM of (NH4)2SO4 
in 100 mM TrisHCl buffer at pH 9.  Evolved nmol quantities of H2O2 via the activity 
of the L-AAO upon the amino acid being produced by PAL for 1 hour 30 mins were 
detected. 
2.3.8 Creating molecular models for obtained novel mutant PALs 
Modelling the selected amino acid changes into the obtained homology model of 
PAL was done using Accelrys Discovery Studio 1.6 and 2.0 [89]. 
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3. RESULTS AND DISCUSSION 
3.1 DNA Shuffling To Construct Shuffled Mutant bsLDH 
During the relatively short history of protein engineering two major approaches for 
altering enzymic activity on known protein scaffolds have emerged, namely rational 
design and directed evolution. Rational design requires knowledge of the relationship 
between structure and function in the enzyme scaffold, prediction of appropriate 
amino acid changes and realization of these changes by site-directed mutagenesis and 
also protein production before testing for the new activity. Directed evolution 
approaches require a method of producing many randomly mutated coding genes and 
a procedure for screening transformed bacteria that overproduce the protein with the 
new activity. However, if these conditions are met, random mutation and selection 
have the great advantage of avoiding the difficulties in obtaining incisive structure–
activity relationships (SARs) thus successful predictive molecular modeling 
techniques. Consequently, various methods of directed evolution have been widely 
adopted by the biotechnology industry and have been proven valuable in 
ameliorating enzyme properties evolving new functions and in manipulating 
metabolic pathways [96]. Mutation-selection also has great potential for feeding 
information back into the rational design approach, if SAR data can be obtained post 
hoc [97-99].  
The bsLDH enzyme is extremely stable to thermal denaturation, but has limited 
substrate specificity. Early studies [51] showed that a complete switching of 
substrate specificity of bsLDH from pyruvate to oxaloacetate by rational design can 
be achieved by replacement of the Glu residue at position 102 to an Arg residue, 
found in the naturally occurring MDHs. More recently [59], the substrate specificity 
of bsLDH has been successfully altered by a semi-rational approach in which 
residues on the substrate-specificity loop were subjected to randomization. The 
bsLDH protein carrying the Gln102Val mutation catalyzes the reduction of 
phenylpyruvate as efficiently as the wild-type enzyme with pyruvate. Allen and 
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Holbrook [60] introduced a DNA shuffling approach to produce a novel bsLDH that 
no longer requires the allosteric activator FBP for maximal activity, a clear industrial 
benefit. 
In this study, two strategies of protein engineering have been applied that can 
potentially create an MDH from a LDH. The problem of altering substrate specificity 
has been approached from opposite poles. The reason for that a rationally designed 
MDH-the Gln102Arg variant has been obtained. 
3.1.1 DNA shuffling 
Applying DNA shuffling to the bsLDH gene involved isolating the coding DNA (an 
about 1 kb fragment) with a 5′ region containing an EcoRI site and a 3′ region with a 
PstI site.  
The gene was then randomly cleaved with a non-specific endo-DNAse I followed by 
PCR without primers to amplify the fragments. The library of mutated full-length 
genes was generated by another round of PCR in the presence of the primers for the 
5′ EcoRI (N-terminus) and 3′ PstI (C-terminus) sites. This library was ligated back 
into pKK223-3 plasmid, transformed into E. coli (JM105) cells and plated out. In the 
second cycle of PCR, the product would be obtained in different sizes. This would 
lower efficiency of transformation due to inclusion of undesired fragments of DNA. 
Later, the colonies were blotted onto nitrocellulose filters, heat-stepped to denature 
the mesophilic E. coli proteins and treated with assay buffer containing malate, 
NAD
+
, PMS and NBT. Colonies producing mutant bsLDH with MDH activity 
generate nicotinamide adenine dinucleotide (NADH), which are chemically coupled 
to the colour reaction giving a purple halo. After the first round of mutagenesis, 83 
colonies were analysed whether they had purple halo or not. 11/83 colonies having 
purple halo were picked up and checked out if they have shuffled-bsLDH in their 
plasmids. Only one of these 11 colonies had shuffled-bsLDH insert and showed 
MDH activity. The colony showing MDH activity was grown up and analysed by 
SDS-PAGE. Then, the active protein was expressed and purified. This screening 
result also demonstrated that some of the problems could occur with this assay. It 
was observed, in our experiment, that ineffective lysis of bacterial colonies and 
failure to remove unbound materials off the filters could lead to false positive 
reactions. After sequencing this shuffled gene (shuffled LDH), we identified eight 
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amino acid changes (Asn18Gln, Ser35Thr, Gln102Arg, Thr108Ser, Ala189Val, h, 
Gln238Asn and Val285Thr) and two silent mutations (Ala25Ala and Val147Val). 
3.1.2 Gln102Arg-bsLDH and shuffled-bsLDH 
As described above, the rational design approach was used nearly twenty years ago 
to switch the activity of bsLDH from pyruvate/lactate to oxaloacetate/malate by a 
single residue change, Gln102Arg, in the substrate-specificity loop [51]. This residue 
change provides the binding site for the second carboxylic acid group of oxaloacetate 
and is characteristic of known malate dehydrogenases. One of the eight mutations in 
shuffled-bsLDH is indeed this ‘switch’, Gln102Arg. We have re-investigated this 
single-mutant bsLDH to enable a fuller kinetic comparison with shuffled-bsLDH. In 
this way, we can ascertain the effect of the other seven mutations upon the shuffled-
bsLDH enzyme. It has long been recognized that native bsLDH is allosterically 
activated by FBP [100]. Kinetic experiments were performed both in the presence 
and in absence of FBP since this was not examined in the original work on 
Gln102Arg-bsLDH. Data was also obtained for the chemically stable substrate α-
ketomalonate, since decarboxylation of oxaloacetate to pyruvate can confuse the 
interpretation of kinetic rates obtained with oxaloacetate and enzymes possessing 
poor MDH but good bsLDH activity. Table 3.1 summarizes the data obtained for 
native, shuffled and Gln102Arg-bsLDH with pyruvate, oxaloacetate and α-
ketomalonate, with and without FBP. 
3.1.3 A comparison of activities with oxaloacetate in the presence of FBP 
BsLDH catalyses the interconvertion of an oxo-acid (pyruvate) and hydroxyl acid 
(lactate) using the NADH/NAD
+
 pair as a redox cofactor. The bidirectional reaction 
is usually monitored by measuring spectrophotometrically either the increase in 
NADH at 340 nm produced in the lactate to pyruvate reaction or the decrease in 
NADH at 340 nm produced in the pyruvate to lactate reaction. Measuring the 
formation of NADH from NAD in dehydrogenase enzymes is a simple direct way to 
get kinetic data as it allows real time measurement of OD. Since the kinetic study of 
bsLDH with pyruvate and NADH could be carried out under single turnover 
conditions, which are significant in the study of many kinetic mechanisms, the 
reduced nucleotide binds tightly. 
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The bsLDH libraries were screened by using malate as a substrate according to the 
reverse direction of the reaction. As the product of this reaction, NADH was coupled 
with phenazine methosulfate (PMS) and nitro blue tetrazolium (NBT) to give a 
purple halo, which signifies the activity of a bsLDH protein with malate used in the 
screen. However, the kinetic studies of shuffled-bsLDH were carried out with 
oxaloacetate rather than malate for the same reason of wild type LDH as explained 
above. 
As the outcome of the work suggests that the results of kinetic studies are consistent 
with the results of preliminary screening experiments, the claim of using different 
substrates for different experiments can be justified. 
Native bsLDH has a weak KM (3.42 mM) for oxaloacetate and a low catalytic rate 
constant; the kcat is 6.3 s
−1
. In contrast, both the Gln102Arg and shuffled-bsLDH 
have identical low KM values (60 μM) and high activities (kcat 253 s
−1
 and 377 s
−1
) 
respectively. Expressing this as ratios of catalytic efficiencies (kcat/KM) shows that 
the Gln102Arg mutant is about 2200 times more efficient as an MDH than the native 
bsLDH, while shuffled-bsLDH is about 3400 times more efficient. 
3.1.4 A comparison of activities with α-ketomalonate in the presence of FBP 
It has been recently reported that certain lactate dehydrogenases can catalyse the 
decarboxylation of oxaloacetate under standard activity assay conditions [100-101]. 
This can result in apparent MDH activity as the LDH turns over the pyruvate 
produced by decarboxylation. The compound α-ketomalonate is an alternative MDH 
substrate that binds into the active site in a position analagous to oxaloacetate [102] 
and is not sensitive to decarboxylation.  
Although the KM of α-ketomalonate is some 20-fold higher than oxaloacetate for 
native bsLDH, the kcat is only some 3-fold slower. The activities against α-
ketomalonate with Gln102Arg-bsLDH and shuffled-bsLDH enzymes are kinetically 
indistinguishable, with kcat around 250 s
−1
 (similar to Gln102Arg-bsLDH with 
oxaloacetate) and KM around 3 mM, some 50-fold higher than with oxaloacetate, 
reflecting the difference seen with native bsLDH. 
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Table 3.1 : Steady-state kinetic constants for native and mutant bsLDH proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.5 A comparison of activities with pyruvate in the presence of FBP 
Both Gln102Arg-bsLDH and shuffled-bLDHs are about two orders of magnitude 
less active with pyruvate than native bsLDH, although the kcat of shuffled-bsLDH is 
twice that of the single-mutant Gln102Arg-bsLDH. However, the KM for pyruvate is 
some 30-fold higher for shuffled-bsLDH than Gln102Arg-bsLDH; this is the most 
striking kinetic difference between these two proteins. The consequence of the raised 
KM for pyruvate with shuffled-bsLDH is that the reduction in catalytic efficiency 
compared with native bsLDH is about 70,000-fold, while that of Gln102Arg-bsLDH 
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is reduced by about 4000-fold. The discriminatory power of the two mutant proteins 
between pyruvate and oxaloacetate is given by the ratio of their catalytic efficiencies 
for each substrate. Hence, Gln102Arg-bsLDH discriminates for oxaloacetate over 
pyruvate by a factor of 8000 while that of shuffled-bsLDH is 200,000. 
3.1.6 The influence of FBP upon the reaction kinetics 
Crystallography has shown that the major effect of binding the allosteric activator 
FBP to bsLDH is the repositioning of the active site residue R171 to bind the 
substrate carboxylate group more tightly [103]. This results in a 40-fold reduction in 
the KM for pyruvate while reducing kcat less than 2-fold. This effect on the kinetics of 
native bsLDH is almost entirely attenuated in the case of oxaloacetate and somewhat 
reversed in the case of α-ketomalonate (KM is raised 3-fold in the presence of FBP). 
The kinetic constants of Gln102Arg-bsLDH with all three substrates are essentially 
unaffected by the presence or absence of FBP. There is no reason to suppose that the 
Gln102Arg mutation will adversely affect the binding of FBP to the enzyme, hence 
any structural influence of FBP binding is not effectively propagated to the active 
site when the Gln102Arg switch is made. Likewise, the kinetic constants of shuffled-
bsLDH with α-ketomalonate are insensitive to FBP. In contrast, minor effects of FBP 
are observed for shuffled-bsLDH with the other two substrates. For pyruvate, the 
effect is reversed compared with native bsLDH, such that the KM is raised about 3-
fold in the presence of FBP. In the case of oxaloacetate, the effect of FBP is 
expressed in the kcat rather than the KM value, such that the presence of FBP 
accelerates the enzyme by a modest 1.4-fold. Although these effects are small, they 
do indicate that the FBP binding site in shuffled-bsLDH is preserved despite the 
proximal mutation, A189V. Therefore, we can say that the mutants of shuffled-
bsLDH are not able to be analog of mutants described by Allen and Holbrook [60].  
3.1.7 The roles of the eight mutations in shuffled-bsLDH 
The eight mutations are discussed here in the light of the model of shuffled-bsLDH 
constructed on the native bsLDH structure. The general similarities of the kinetic 
properties of Gln102Arg-bsLDH and shuffled-bsLDH illustrates that the Gln102Arg 
mutation is responsible for the majority of the switch from LDH to MDH activity in 
these proteins. 
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Fig. 3.1(a) shows how the Gln102Arg mutation allows oxaloacetate to bind in the 
active site pocket in a pose consistent with the chemical reaction. This supports the 
original rational design strategy and is also consistent with the mode of binding of α-
ketomalonate to porcine MDH as determined by crystallography [104]. The 
remaining seven mutations are broadly chemically conservative and located at or 
close to the surface of the protein. The positions of the changes in the context of the 
monomer are shown in Fig. 3.1(b) and in the context of the tetramer in the (Fig. 
3.1(c)). Three residue changes, Asn18Gln, Gln238Asn and Val285Thr are remote 
from the active site, cofactor binding pocket and any subunit interface hence they are 
unlikely to affect the catalytic activity. Likewise, the mutation Ser35Thr is unlikely 
to affect activity since it is located at the “dimer” interface on the Q-axis, which is 
retained in the conversion of tetramer to dimer that accompanies removal of the FBP 
activator and is remote from the FBP site. The three remaining mutations are all 
possible candidates for modulating the activity of shuffled-bsLDH compared with 
Gln102Arg-bs. The mutation Thr108Ser in the substrate-specificity loop may be 
partly responsible for the 30-fold higher KM for pyruvate shown by shuffled-bsLDH 
compared with Gln102Arg-bsLDH, since this change will increase flexibility of the 
loop, which is required to become ordered on substrate binding. The FBP-dependent 
effects exhibited by shuffled-bsLDH, raised KM for pyruvate and raised kcat for 
oxaloacetate, are probably caused by perturbations around the FBP site caused by the 
nearby Ala189Val mutation. Finally, the residue at position 199 is close to the 
catalytic histidine 195 (6.2 Å, Glu199:CD-His195:CG) in the bsLDH crystal 
structure, hence the change Glu199Asp may modulate activity by structural or 
electronic perturbations. 
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Figure 3.1 : a) Upper image shows oxaloacetate modelled into the activesite 
of shuffled- bsLDH after energy minimisation; lower image 
shows a similar view of the crystal structure of wild type 
bsLDH with pyruvate and NADH; and shows oxaloacetate 
modelled into the active site of shuffled-bsLDH after energy 
minimisation; b) the positions of the mutations in shuffled-
bsLDH and c) the positions of the mutations in shuffled-
bsLDH in the context of the tetramer (mutations are red, 
NADH is green, FBP is yellow and oxaloacetate is blue). 
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3.2 Mandelic Acid as a Substrate for Highly Purified Bacillus 
stearothermophilus Lactate Dehydrogenase  
3.2.1 Expression and purification of mutant and native bsLDH proteins 
After each PCR reaction, the DNA product isolated after plasmid purification was 
loaded onto an agarose gel. The results of the agarose gel electrophoresis indicated 
that the linear plasmid was amplified.  The  product  plasmids  were  digested  and  
run  on  an  agarose  gel prior  to  sequencing. Site-directed  mutagenesis  was  used  
to  insert  mutations  at  two  positions  in  the bsLDH gene, generating the double 
variant. Presence of the desired mutations was confirmed by DNA sequencing.  
BsLDH with 6xHis-tags were purified using the TAGZyme system. Affinity of the 
6xHis tag for the chromatography resin facilitates purification of bsLDH      
(Fig.3.2). The lane corresponding to the final protein (lane 4) indicates that bsLDH  
is close to 95 % pure. 8μL for samples of the purified native and mutant bsLDH 
enzymes from each step were loaded onto a (12 % w/v) standard SDS-PAGE gel. As 
is evident in the final elution samples (lane 4) shown in Fig.3.2, wild type and  
mutant enzymes were obtained in high yield and had  no unexpected bands on the 
gel, indicating the isolated proteins were free of contamination (Table 3.2). 
 
Figure 3.2 : Expression and purification of 6xHis-tagged wild-type  and  mutant 
bsLDH from E. coli protein fractions of SDS-PAGE gel. (M) Standard               
protein marker (Unstained standard protein weight marker, Fermentas 
Inc.) (1) Supernatant of the whole cell lysate. (2) Column wash. (3) 
Fractions of the wild type elution. (4) Fractions of the mutant elution. 
(Numbers on left show the molecular weight-kDa). 
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Table 3.2 : Comparison of the purification system for obtained purified bsLDH. 
 
The steady-state kinetic parameters for bsLDH were calculated.  The average final 
concentration of bsLDHs in elution buffer was 0.53 mg/mL (lane 3-4). 
Characterisation of the native and mutant bsLDH proteins has been facilitated by the 
utilisation of modified expression and purification protocols. Many recombinant 
proteins are produced by intracellular expression of heterologous genes in genetically 
engineered E.coli strains. The previous bsLDH purification strategy utilised a 
combination of ammonium sulphate fractionation, ion exchange chromatography, 
and blue sepharose affinity chromatography. However, these methods are time-
consuming and are not suitable for high protein yield and purity. We, therefore, 
looked for a simple method of purification that does not compromise the purity and 
yield of active bsLDHs. The TAGZyme system, described in the previous section, 
provides a quick and efficient method for obtaining purified active enzyme. By 
application of the TAGZyme system, enzyme was isolated with increased purity and 
decreasing time and complexity of purification. While the TAGZyme system 
provides the advantages described above, it may affect the kinetic constants of 
enzymes. After cloning bsLDH into a 6xHis-tag expression vector, the protein was 
obtained in greater than 95 % purity in just three hours from a small scale, with no 
effect on enzyme. A final dialysis step against active charcoal was added to the 
purification protocol to remove salts and nucleotides from the product bsLDHs. 
3.2.2 Enzyme assay of mutant and native bsLDH proteins obtained by                    
TAGZyme system 
The steady-state catalytic properties of the mutant and native bsLDHs obtained by 
the TAGZyme system were compared to those obtained by the standard 
chromatographic method. The average yield of bsLDHs in the last step of TAGZyme 
purification was 0.53 mg/mL. The kinetic constants for native bsLDH purified by the 
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former standard method [104] are compared to those of bsLDHs purified with the 
TAGZyme system in Table 3.3 and Table 3.4. 
Table 3.3 : Summary of the kinetic parameters kcat and KM for His-Tagged and 
                   wild-type bsLDH.  
Table 3.4 : Steady-state kinetic properties of native and mutant bsLDH proteins with 
        various substrates.    
 
The Michaelis constant (KM) of 6xHis-tagged bsLDH  is reduced relative to that of a 
stock of wild type bsLDH without the 6xHis-tag, indicating that the affinity of 6xHis-
tagged bsLDH is better than the analogous untagged enzyme. Thus, addition of the 
6xHis-tag to the C-terminus of bsLDH does not cause any significant change in its 
conformation. 
3.2.3 Molecular modeling of mutated bsLDH protein 
Residue replacement and rotamer optimisation were conducted using the molecular 
modeling software Insight II, emphasizing the maintenance of bsLDH’s ability to 
facilitate redox chemistry. A representation of the designed mutant active site in the 
enzyme:NADH:L-mandelic acid complex is shown in Fig.3.3. 
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Figure 3.3 : Shows mandelate modeled into the active site of the mutated-bsLDH 
                      after energy minimization. 
A detailed understanding of the structure and mechanism of bsLDH is needed to alter 
the substrate binding site of the enzyme while maintaining the elements essential for 
catalysing the redox reaction. This is particularly difficult in an enzyme with many 
amino acid residues and regions important for both catalysis and substrate specificity 
in the vicinity of the active site. The X-ray crystal structure of bsLDH [105] allowed 
identification of the active site for 2-hydroxy acid dehydrogenation. Previous studies 
revealed the catalytic importance of His195 as a proton donor/acceptor [25,108] and 
supports the existence of His195 in the protonated form in the ternary complex 
[104,48]. Furthermore, Ile250 contributes to the hydrophobic environment for the 
dihydronicotinamide ring [48], Arg109 stabilises negative charge on the substrate 
C2-oxygen in the transition state [109], R171 provides a tight, bifurcated binding-
interaction with the C1-carboxylate of the substrate [47] and Thr246 constrains the 
volume of the active site. The role of these amino acids in substrate specificity has 
been examined in previous studies in which these residues were replaced by smaller 
variants in an attempt to increase the size of the substrate-binding cavity [51,56,110].  
There is also evidence that the specificity of bsLDH is determined by at least two 
regions of the enzyme surrounding the side chain of the substrate. These regions 
consist of a flexible polypeptide loop that folds over the active site and encloses the 
substrate in the catalytic pocket, and a helix onto which this loop folds [109]. To 
accommodate substrates with hydrophobic side chains larger than that of the 
G246 
A240 
I241 
NADH 
A239 
R171 
D168 
H195 
R109 
 
 
 
 
 
 
mandelate 
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pyruvate substrate, mutations were introduced to these two loops. Gln102Met, 
Lys103Val, Pro104Ser and Ala236Gly, Ala237Gly mutations increase the tolerance 
for large, hydrophobic branched-chain substituted pyruvate variants. These changes 
resulted in a 55-fold improvement in kcat with α-ketoisocaproate as a substrate [53]. 
In the first attempt to change the substrate specificity of bsLDH, Atkinson and 
colleagues designed bsLDH to change the preferred substrates from the 
pyruvate/lactate pair (R=CH3) to the oxaloacetate/malate pair (R=CH2-COO). The 
volume of the active site was increased with a Thr246Gly mutation, an acid was 
neutralised with an Asp197Asn mutation and a base was introduced for charge 
pairing with a Gln102Arg mutation. This triple mutant had a catalytic specificity for 
oxaloacetate over pyruvate of 500 compared to 1000 for the native of bsLDH [50]. 
A short sequence comparison indicates that residues Thr246 and Ile240 are not well 
conserved in dehydrogenases for different substrates, supporting the idea that they 
are important in substrate selection. Examination of the structure native state bsLDH 
enzyme reveals that Ile240 occupies the substrate binding space. Thr246 is close to a 
tight turn (aa 235-238) between two helices that, together with the mobile coenzyme 
loop (aa 99-110), shield the bound substrate and the nicotinamide moiety of NADH 
in the active site from the solvent [108]. The restriction of active site volume 
imposed by the Thr246 (Fig. 3.3) residue may be responsible for the preference for 
α-hydroxy acid substrates with small side chains. The hydroxyl group of Thr246, 
which is part of the active site wall, is favourably positioned to form a hydrogen 
bond to the carboxylic group of the substrate [45].  
Residues Ile240 and Thr246, conserved in all LDHs, are smaller residues in mandelic 
dehydrogenase (ManDH), presumably to enlarge the volume of the binding pocket 
and to accommodate the increased size of mandelic acid. Holbrook et al. 
demonstrated that replacement of Thr246 with Gly in the bsLDH active site changes 
the preference for the new substrate over the old, resulting in a 3200-fold reduction 
in the kcat/KM for pyruvate and a slight enhancement for oxaloacetate. Thus, Thr246 
can affect substrate specificity [51]. 
Wilks et al. targeted 2-oxo and α-hydroxy acids with hydrophobic groups as new 
substrates for the Thr246Gly mutant of bsLDH. They strategised that the Thr246Gly 
mutation could accommodate the larger side chains of α-hydroxy acids with 
hydrophobic groups. The kinetic data support this hypothesis only when the side 
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chain of the substrate is charged, as in the case of oxaloacetate. In this case, the 
deleterious effect of the Thr246Gly mutation is reversed due to better substrate 
binding, reflected by the KM values. As mentioned before, the hydroxyl group of 
Thr246 is part of active site wall that forms a hydrogen bond with carboxylic group 
of the substrate. Thus, the Thr246 residue can help dictate preference for small side 
chain α-hydroxy acids. Replacement of Thr246 with Gly eliminates the possibility of 
this hydrogen bond and the substrate binding and orientation it facilitates. 
Additionally, in the specific case of oxaloacetate, water cannot access to the critical 
active site region in the Gly mutant typically occupied by the side chain of Thr246 
[110].  
Introduction of mandelic acid as a substrate for LDH was achieved previously by 
engineering Saccharomyces cerevisiae falvocytochrome b2: (LDH). A specific 
mandelate dehydrogenase was designed from the LDH framework via two mutations 
(Ala198Gly, Leu230Ala) that increased substrate specificity for mandelic acid 400-
fold over the native enzyme [62]. 
Substrate binding in the wild-type enzyme is achieved by formation of a hydrogen 
bonding network that excludes water. As the size of substrate side chain is increased, 
reorientation of the loop may increase the accessibility of water to the active site, 
thereby decreasing rates of enzyme catalysis.  These water molecules may provide 
alternative H bond partners to various functional groups in the active site. The larger 
side chain substrates may have a similar effect as water on the active site, such that 
further increases in size have no additional effects [54]. 
These previous studies showed that bsLDH is sensitive to the charge and size of α-
hydroxy acid side chains. Thus, it is likely that bsLDH is unable to catalyse the 
oxidation of L-mandelate because steric interference between the substrate and the 
side chain of Thr246. The steric interactions force L-mandelate to adopt an 
unfavourable orientation for proton abstraction at C-2, which may prevent the 
formation of the transition state. Thr246, a catalytically important residue, restricts 
the orientation of the mandelate ring. Thus, the redesign of bsLDH, while 
maintaining the important functions of Gln102, His195, Asp68 and Arg171, is 
necessary to accommodate the large side chain mandelic acid. This was 
accomplished by enlarging the volume of the active site pocket and orienting 
substrate/protein contacts. Residues Ile240 and Thr246 were replaced by amino acids 
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with small side chains to enlarge the volume of the binding pocket and remove 
possible interactions between the side chain of Thr246 and the aromatic ring of 
mandelic acid.  
Although no additional experimental studies on the role of Ile240 have been 
conducted, X-ray structure and modelling studies of bsLDH indicate that Ile240 is 
close active site residues and forms a cavity for binding the substrate, as shown in 
Fig. 3.3. Substituting Ile240 with alanine introduces nucleophilic charge repulsion 
with the second -COO of new substrate, resulting in a correct orientation for 
aromatic ring of mandelic acid. 
The modelling studies indicated that replacement of Thr246 with Gly most likely 
leads to a stronger interaction and better binding between the new substrate and 
Arg171, a hypothesis supported by the KM value for mandelic acid.  Due to the Gly 
mutation, H bonding with Thr246 is predicted to be eliminated, allowing the 
aromatic ring of mandelic acid to orientate with Arg171, as seen in Fig.3.3.  
Furthermore, the aromatic ring of mandelic acid excludes external water from the 
increased binding pocket formed by the Thr246Gly mutation. Introducing Gly can 
contribute stabilisation to the mentioned catalytic pocket. 
The hydrophobic residues Ala237, Ile240, Ile241 orient the -CH3 of Thr246 that 
interacts hydrophobically with the -OH of the substrates. Replacing Thr246 with Gly 
eliminates the effects of these amino acids on Thr240, thereby decreasing the binding 
energy for the substrate. However, substituting the methyl side chain of the substrate 
with an aromatic group generates new interactions between the protein environment 
and L-mandelate that resulted in increased binding energy. The decreased KM can be 
rationalised by these new interactions. 
Substituting only Ile240 with any small side chain amino acid may increase the 
substrate binding pocket to accommodate the aromatic side chain of the substrate, but 
this single mutation cannot influence the binding because of the its location that is in 
outside of the α-helix. However, substituting Thr246 with Gly removes a hydrogen 
bond with the substrate so that the binding energy for substrate will decrease. 
Furthermore, the CH3 of the Ala240 mutant makes hydrophobic interactions with 
aromatic side chain. 
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These mutations resulted in an enzyme with an increased volume of its binding 
pocket. His195, Arg171 and Gln102 orient the substrate and transfer H
-
. Ultimately, 
simulations suggested that moving the substrate away from these active residues and 
towards the Gly246 and Ala240 mutations would lead to a decrease in kcat. 
The major rate-determining step for bsLDH catalysis is proton abstraction at C-2 of 
lactate. Thus, the reaction rate for the double mutant bsLDH reports on the 
interaction between mandelate and active site amino acids. The electrostatic 
interactions of mandelic acid with the crucial Arg171, Gln102, and His195 amino 
acids suggests a more favourable interaction between the aromatic group of mandelic 
acid and the Gln102 and Arg171 side chains. An electrostatic interaction may exist 
between the polar group on the 102 residue and the aromatic ring of the substrate or 
via a number of mechanisms.  
The improved activity of the double mutant compared to the wild type when 
mandelic acid is the substrate suggests that a combination of better electrostatic 
interactions and H-bonding between mandelic acid and the active site residues. The 
combined effects of Gly246 in orienting and accommodating the large side chain of 
mandelic acid and of Ala240 in supplying more space for mandelic acid are 
responsible for also improved substrate binding. 
The most impressive aspect of this study is being the first time success in introducing 
the substrate having aromatic side chain. Therefore, these observations led to the 
suggestion that Thr240 and Ile246 might be crucial residues in accommodating and 
orienting large side chain substrates for bsLDH.  
 3.3 Development of Novel Ammonia Lyase Biocatalysts for the Production of 
Unnatural Amino Acids for Industry 
3.3.1 Optimisation a screening method for PAL variants  
Finding a screening method allowing scanning libraries which have thousands of 
mutant colonies for the desired properties of engineered enzyme in a short time is a 
key requirement for any directed evolution experiments. Therefore, primarily the 
development of both a high-throughput solid phase screen and a microtitre plate 
based assay to identify and characterize PAL activity was focused on. 
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3.3.1.1 A pH sensing agarose plate solid assay  
Any colour shift after overnight incubation at 30 
o
C for pH sensing agarose plate 
assay was not seen. The similarity pKa of pH indicator to the pH of the reaction 
mixture ensures that the change of pH leads to a large and linear colour change. It is 
extremely important to choose an appropriate pH indicator and buffer pair for 
accurate measurement of PAL activity. The main selection criterion is that the pKa 
of the buffer and the pKa of the pH indicator should be as close to equal as possible. 
Desired pH indicator should work most sensitively at pH<8. The colour of the 
selected pH indicator will gradually change from the colour of used indicator to the 
coupled of different colour with increasing amount of protons generated by the 
enzyme.  Chosen buffer should have pKa that is very close to that of selected pH 
indicator dye.  The selected reaction mixture should be low enough to maximize 
sensitivity, while high enough to ensure accurate measurements and small pH 
changes throughout the assay. The small pH changes are important because kinetic 
parameters may change with changing pH. 
3.3.1.2 The solid phase of growth screen 
Another solid phase screen based on utilising the release of nitrogen due to 
enzymatic activity of PAL to support bacterial cell growth. The observed growth is 
because of nitrogen released, due to the activity of the PAL enzyme on the amino 
acid as a substrate. However, the forming of colonies was not observed even after 6 
days on Petri plates having M9 media-NH4Cl, phenylalanine.  
A liquid phase assay has been developed by Rowles, which was a construct of the 
assay by Khan and Valdyananthan [94]. This assay 1 (Fig.3.4) was applied to the 
screening of small libraries of PAL variants such as those generated during a 
CASTing experiment.  
To aid with the identification of these protein variants two novel assays have been 
developed for the screening of PAL activity. Assay 1 is a high-throughput whole cell 
microtitre plate based assay for the deamination reaction of the PAL enzyme. This is 
applicable for the screening of small focused libraries of PAL variants. Assay 2 is for 
the determination of the synthetic activity of PAL; this assay uses an enantioselective 
oxidase enzyme and horse radish peroxidase (HRP) as a reporter system for PAL 
activity (Fig.3.4).  
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Figure 3.4 : The reaction catalysed by the PAL enzyme and the two developed 
                          screenings to detect the activity.  
3.3.2 Constructing mutant PALs based on generating the CASTing libraries 
An alternative strategy combinatorial active-site saturation test introduced for 
expanding substrate acceptance of PAL. Based on the obtained three-dimensional 
structure of the enzyme by homology modeling, sets of five amino acids, whose side 
chains reside next to the binding pocket, are identified and the respective positions 
are then randomized simultaneously with the creation of relatively small libraries of 
mutants. By this method, mutant PALs that have more activity 4-Br-CA than the 
wild type have been able to obtained. 
3.3.2.1 Generation of saturation mutagenesis libraries  
On the basis of the homology modelling structure, five CASTing libraries A, B, C, 
D, E(calling as 1-5 respectively as well) were chosen for saturation mutagenesis 
using NRT codon degeneracy which encodes Arg, Asn, Asp, Cys, Gly, His, Ser, Tyr. 
Selected candidate residues composing of five CAST sites to be randomised 
simultaneously: His145, Gln146, Leu217, Leu274, Val277, Asn278, Tyr371, 
Asn404, Phe420, Arg474, Lys475, Ile479, Glu503, Asn506. The substrate and 
175211 are phenylalanine is MIO respectively in the results of modelling figures 
(Fig.3.5-11). 
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The CASTing site of A of the active site of PAL is based on His145 residue. 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 : Showing the CASTing sites of A; distance among the selected amino 
               acids and substrates. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 : Showing the CASTing sites of  A; distance among the selected amino 
                       acids and substrates.  
The CASTing site of B of the active site of PAL is based on Asn278 residue. 
 
 
 
 
 
 
 
Figure 3.7 : Showing the CASTing sites of B; distance among the selected amino 
                     acids and substrates.  
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 The CASTing site of C of the active site of PAL is based on Arg374 residue. 
 
 
 
 
 
 
 
 
Figure 3.8 : Showing the CASTing sites of C; distance among the selected amino 
                     acids and substrates.  
 
The CASTing site of D of the active site of PAL is based on Glu503 residue 
 
Figure 3.9 : Showing the CASTing sites of D; distance among the selected amino 
                     acids and substrates.  
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Figure 3.10 : Showing the CASTing sites of D; distance among the selected amino 
                       acids and substrates.  
 
 
 
 
 
 
 
 
 
 
Figure 3.11 : CASTing of PAL leading to the construction of five libraries of   
           mutants (A–D) produced by simultaneous randomization at  
           different number of amino acid sites for each library.                                        
3.3.3 Screening of saturation mutagenesis library and purification of selected 
novel mutant PAL enzymes 
All libraries were screened for lyase activity against 4-bromophenylalanine, which 
are not accepted by the wild type PAL [83]. This multiple-substrate/step screening 
required 3000 colonies high throughput screening. Although the simultaneous 
randomization of a few amino acids yields hundreds unique variants (some being 
double mutants, others having only a single amino acid exchange plus the original 
wild type combination), the number of variants to be screened depends on the 
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randomization technique used in the construction of a library and on the over-
sampling required for 95 % coverage of protein-sequence space [110]. Screening of 
all libraries was accomplished. The purification of the selected novel mutant PAL 
enzymes was carried out. 
3.3.3.1 Sequence results for the selected novel mutant PAL 
Library A  
  421 - GCT TTG ATC GAA CAT CAA CTC TGC GGC GTA ACT CCT ACC - 465  
  141 - A       L      I       E        H      Q       L      C       G      V       T       P      T     -155  
                                       145             146 
Wild Type PAL:           HISTIDINE         GLUTAMINE 
Mutant diversity of library A after sequenced selected with the screening: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GLYCINE SERINE 
ASPARAGINE SERINE 
GLYCINE GLYCINE 
GLYCINE CYSTEINE 
SERINE SERINE 
GLYCINE GLYCINE 
SERINE ASPARAGINE 
SERINE GLYCINE 
ASPARAGINE ASPARAGINE 
CYSTEINE ASPARAGINE 
GLYCINE ASPARAGINE 
CYSTEINE SERINE 
SERINE CYSTEINE 
ASPARTIC ACID ARGININE 
CYSTEINE CYSTEINE 
PROLINE ASPARAGINE 
CYSTEINE ASPARTIC ACID 
GLYCINE ASPARTIC ACID 
CYSTEINE GLYCINE 
ASPARAGINE CYSTEINE 
ASPARAGINE TYROSINE 
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  Library D  
  1381- CCT TCT CTC AAT TAT CAC GGT AAG GGG CTG GAC ATC -1418  
  468 - S      L      N     Y       H      G       K      L       L       D      I        I   - 479  
                             475                                     479 
Wild Type PAL:    LYSINE                         ISOLEUCINE 
Active Mutants of Lib.D after screening 
Mutant*:               ASPARTIC ACID           HISTIDINE 
*(inserted primer itself having these mutant but not broken in open reading frame) 
Sequence of the mutant: 
...ANY_HGRGLDGHIAAY(CTCAATTATCACGGTGATGGTCTGGACCATCAT
ATTGCAGCG)ASEL. 
Library E  
 1501 - GAA ATG GGT AAC CAG GCT GTC AAT TCT CTG GCG CTG -1545  
   503 - E       M      G      N        Q      A      V      N       S      L       A       L      - 515  
                            503                                  506 
Wild Type PAL: GLUTAMINE             ASPARAGINE 
Active Mutants of Lib.E after screening 
Mutant:               GLYCINE                    ASPARTIC ACID 
The mutant PAL enzymes having 6xHis were purified the by using a modified 
method of Qiaexpresionist by QIAGEN [63]. SDS-PAGE analysis (Fig.3.12) shows 
that the eluted mutant PAL protein of ~100 kDa and purity of the last eluted fraction 
is more than 90 % for kinetic studies. 
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Figure 3.12 : SDS-PAGE shows the purified mutant PALs with 7 step elution.  
(M): Standard marker (Unstained standard protein weight marker, 
Fermentas Inc.). (1-7): Eluted fractions. (Numbers on left show 
                       the molecular weight-kDa).      
3.3.4 Calculation specific activity of the selected mutants of library A and D 
Specific activities of the colonies from library A and the single colony from library D 
which showing more activity in screening were calculated. 
Table 3.5 : Specific activity calculations for library A and D (Substrate is 4- 
   bromophenylalanine, Activity-nmole/min/mg protein).        
MUTANT 
NUMBERS 
MUTATION 
OF 145 
MUTATION 
OF 146 
 SPECIFIC 
ACTIVITY 
1 Cys Ser 80.50±9.2 
2 Gly Cys 54.90±8.2 
3 Pro Asn 176.20±28.6 
4 Ser Gly 7.90±0.9 
5 Cys Asp 5.70±0.4 
6 Ser Ser 97.70±9.6 
7 Gly Asn 67.99±5.8 
8 Cys Gly 4.90±0.6 
9 Asn Asn 69.24±6.4 
10 Asp Arg 2.92±0.2 
11 Asn Tyr 3.79±0.1 
12 Ser Cys 78.90±14.7 
13    Cys   Asn     109.04±8.9 
Native PAL His Gln 2.30±0.2 
15 Cys Asn 307.28±54.6 
16 Gly Gly 6.16±0.3 
17 Cys Cys 5.56±0.8 
18 Gly Ser 37.25±8.9 
19 Gly Gly 4.81±0.2 
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Table 3.5 (contd.) : Specific activity calculations for library A and D (Substrate is 4- 
                  bromophenylalanine, Activity-nmole/min/mg protein).        
20 Asn Ser 168.34±16.8 
21 Ser Asn 173.32±19.3 
22 Asn His 67.05±4.7 
23 From library D 4.23±0.1 
 
Because of CASTing, many variants were identified as hits. Most of the hits 
originate from library A showing the highest frequency of improved mutants. The 
most promising enzymes namely 16D, 25E, 29B, 31E variants from library A, were 
identified as the double mutant His145Asn/Glu146Ser, His145Ser/Glu146Asn, 
His145Asn/Glu146Cys, His145Cys/Glu146Asn respectively. 
3.3.5 Enantioselectivity of the best mutant 
4-bromophenylalanine is chiral, so it was therefore of interest to study the 
enantioselectivity of the best mutant as catalysts in lyase kinetic resolution. The 
screening system was designed to assess activity, and it is suitable to test the effect of 
mutations on the enantioselectivtity (Fig.3.13) The enantioselectivity of the reaction 
of the best PAL variants was determined. This was conveniently achieved by 
replacing the L-AAO in the assay with D-AAO. A third assay was included as a 
blank where the oxidase was replaced with a buffer solution to determine the 
background decrease in fluorescence. When the blank bar compared with the D-
AAO bar, it can conclude that there is no increase in activity when a D-amino acid 
oxidase is instead incorporated in the assay, thus demonstrating the enantioselectivity 
of the PAL enzyme variants. 
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Figure 3.13 : The enantioselectivity of the best mutant PAL. 
3.3.6 The best mutant PAL pH profile 
The results show that PAL from Rhodotorula graminis has an optimum pH of 10 and 
is performed at 30 °C, the temperature optimum for R. graminis growth for the 
amination reaction, with a tolerance of 0.5 pH units over which the enzyme retains 
>90 % of its activity (Fig.3.14).  
 
Figure 3.14 : The reaction catalysed by the best mutant PAL at the pH 8, 8.5, 9, 9.5. 
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3.3.7 Kinetics of the PAL variants  
The liquid phase assay was used to determine the kinetics of the PAL synthesis 
reaction. To this end, a range of substrate concentrations from 12.5 μM to 1000 μM 
were assayed and the activity of the enzyme at each concentration measured. The 
kinetic parameters of the reaction were then determined with the direct Linear 
method [111]. 
Fixing the concentration of ammonium sulphate at 100 mM the apparent kinetic 
constants KM and kcat were calculated for trans-cinnamic acid. The concentration of 
ammonia was kept at 100 mM so that only the influence of trans-cinnamic acid on 
the kinetics of the reaction is measured (Table 3.5). 
In each nmol of H2O2 evolved, there is a decrease in the fluorescence by 1414.1 
RFU. As can be seen in Fig.3.15, this compound is fluorescent and sensitive in nmol 
level for activity. These results provide a high sensitive detecting kinetic assay for 
PAL enzyme. Kinetic parameters were calculated based on assay 2 in Fig.3.4. 
 
Figure 3.15 : The standard curve of scopoletin fluorescence in the presence of 
                             hydrogen peroxide. 
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Table 3.6 : Summary of the steady state kinetic constants of the PAL variants 
                   against 4- Br-CA. 
 
It is well known that PAL catalyses the reversible non-oxidative deamination of 
phenylalanine to trans-cinnamic acid and ammonia. The reversibility of this reaction 
has been used to synthesise phenylalanine economically at multi-ton scale [112].  
Analogues of L-phenylalanine are incorporated as pharmacophores in several 
peptidomimetic drug molecules and are therefore of particular interest to the fine 
chemical industry.  
Ile479, Lys475 and His145 are in the contact place of monomers.  Asn278 hydrogen 
bonds with the developing enolate oxygen of MIO increase the electro positivity of 
the MIO methyldiene group. His143 is responsible for the abstraction of the pro-S 
hydrogen from C3 of substrate. Development and stabilisation of carbonion are 
provided by the phenyl ring of the substrate whose electrons are polarized away from 
carbonion site from interaction Leu223, Leu274 and Val277. The NH2 adduct is 
stabilised by sharing an H bond with OD1 of Asn270 and by interaction with phenyl 
ring of Phe420.  Breakdown of NH3 and MIO are prompted by donation of a proton 
from the OH group of Tyr371 to the NH2 group. Tyr371 is stabilised by Arg374. So 
Tyr371, Asn278, His145, Glu503, Arg374 are main candidate residues.  
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Using NRT coding Arg, Asn, Asp, Cys, Gly, His, Ser, Tyr as a degenerative codon 
means that obtaining about 500 mutant colonies after transformation is enough to 
cover all possibilities of amino acids encoded by the degenerative NRT codon. 
Therefore, by choosing the NRT codon as the degenerate codon, the number of 
colonies required to be screened by only incorporating amino acids that provide side 
chains that are involved in the majority of catalysis decreased. 
Without a study based on molecular mechanics/quantum mechanics (MM/QM), 
explaining the result is difficult.  However, molecular modeling studies based on 
standard molecular dynamics simulations and the results of published papers can 
help the molecular basis of the recognizing substrate. The results show that a good 
diversity was obtained for library. In this diversity, for the much more activity, one 
of the candidate amino acid of library 1 should have small side chain and another 
should be polar. However, position of both the polar and small side chain amino acid 
is crucial. For library 4; placing Asp and His does not make any charge differences. 
In spite of insertion, primer having same mutant for library 4 of the mutant; having 
correct the open reading frame (ORF) and more activity than native as well.   
The mechanism of the reaction of PAL that is identify the dehydroalanine at the 
active site of the enzyme reacts with the amino group of the substrate, generating a 
positive charge, thus increasing the leaving ability of the ammonium group of 
histidine [113]. The prosthetic electrophile was discovered through experiments 
where the activity of the enzyme was inhibited by strong nucleophiles. The use of 
radiolabelled inhibitors led to the conclusion that the prosthetic electrophile is 
dehydroalanine. This mechanism is not able to exactly define the reaction catalysed 
by PAL because it does not account for the abstraction of the non-acidic β proton of 
L-phenylalanine by an enzymatic base. Despite this deficiency in the mechanism, it 
has been widely accepted for PAL for many years. 
X-ray crystal structure modeling studies proposed an alternative that ascertain the 
precursor of the prosthetic dehydroalanine, which led to the postulation of an 
alternative mechanism for the activity of the ammonia-lyase enzymes PAL [114]. 
The dehydroalanine was originally thought to arise from the dehydration of a Ser 
residue, so mutation experiments were performed that is Ser202Ala in PAL from 
Petroselinum crispum by site-directed mutagenesis. This change resulted in a 
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reduction in enzyme activity by more than a factor of 1000 [115] that supporting the 
crucial role of Ser residue as precursors of the dehydroalanine residue for catalytic 
activity. 
Then a new mechanism of PAL was proposed that is a Friedel-Crafts type attack of 
the imidazole ring by the prosthetic electrophile [115]. It has been observed that 
recombinant PAL from Petroselinum crispum reacts faster with m-tyrosine than its 
natural substrate; this suggested that the mechanism of PAL was a Friedel-Crafts 
type reaction [116]. 
Finally, the evidence of X-ray structure for a member of lyase family histidine 
ammonia lyase (HAL) provided that the prosthetic electrophile was not 
dehydroalanine but the Michael acceptor MIO [112]. The prosthetic electrophile can 
be regarded as a modified dehydroalanine residue formed by the post-translational 
cyclisation of the inner tripeptide Ala142-Ser143-Gly144, during which two water 
molecules are eliminated [112]. MIO is much more electrophilic than dehydroalanine 
making the Friedel-Crafts attack at the aromatic ring of phenylalanine feasible [117]. 
The proposed mechanism of action of PAL is a Friedel-Crafts type attack of the 
phenyl moiety by the prosthetic electrophile MIO (Fig.3.17-18) [118]. 
The recent crystal structures of the same family of PAL enzyme have provided 
further evidence for the elimination type mechanism for the MIO containing 
enzymes [119-120]. 
A paper has showed the existence of a glutamic acid in PAL enzyme family leads to 
the initial binding of the substrate in the active site and indicates that the Friedel-
Crafts type attack is favoured [121]. 
All of our studies have focused on the active site pocket, the investigation regarding 
the enantioselectivity, pH and the kinetic resolution. In this study, it was 
demonstrated that due to directed evolution both the preferred enantioselectivity and 
high kinetic rates for industrial application of mutant enzyme were obtained.  
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Figure 3.16 : The elimination mechanism of PAL[118]. 
The theoretical analysis for ammonia lyase family enzymes based on QM/MM 
studies pinpointed one of the crucial mutations as being His145 (146)/Ser (Cys), 
which is next to the binding pocket and close to the MIO.  It became clear that the  
mutational change His145(146)/Ser(Cys) causes, among other things, theenlargement 
of the binding pocket to accommodate the brom at the aromatic ring of 4-Br-CA, that 
is, to tolerate branching. This result is relevant to the present analysis. 
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Figure 3.17 : The Friedal-Crafts type mechanism of PAL[118]. 
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Figure 3.18 : The modeling of the wild type and best mutant PAL with 4-Br-CA. 
The mutational changes in 29B, namely His145Asn and Glu146Cys, can be 
interpreted as follows. The side chain of Cys is sterically smaller than that of the 
original Gln, thereby providing more space for binding bulky (branched) substrates. 
Histidine has a positively charged side chain not making easy the Friedel-Crafts type 
attack. As mentioned above, electorophilic MIO cannot eliminate in the existence of 
positively charged residue (His145). So replacing the His with Asp or any uncharged 
amino acids (Ser, Cys) makes fast the elimination of MIO meaning increasing kinetic 
rate for PAL variants.  
 
 
WILD TYPE PAL 29B MUTANT PAL (C145N146) 
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APPENDIX A: Vectors 
 
 
Figure A.1 : Plasmid map of pKK 223-3 vector. 
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Figure A.2 : Plasmid map of  pQE-2 vector. 
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Figure A.3 : PAL expression vector. 
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APPENDIX B: Unstained Standard Protein Weight Marker (Fermentas Inc.) 
 
Figure B.1 : Unstained Standard  Protein Weight Marker  on 12% polyacrylamide 
            gel. 
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APPENDIX C: Media, solutions and reagents 
LB medium:  10 g/liter tryptone, 5 g/liter yeast extract, 10 g/liter NaCl. 
LB agar:  LB medium containing 15 g/liter agar. 
Ampicillin stock solution: 100 mg/ml in H2O, sterile filter, store in aliquots at         
–20°C. 
IPTG (1 M): 238 mg/ml in H2O, sterile filter, store in aliquots at –20°C. 
50 mM TrisHCl: 6.05 g Tris base (MW 121.1 g/mol) in 1 liter H2O. 
5x SDS-PAGE sample buffer: 0.225 M Tris·Cl, pH 6.8; 50% glycerol; 5% SDS; 
0.05% bromophenol blue; 0.25 M DTT. 
SDS-PAGE running buffer: 3.02 g Tris base, 14.4 g glycine in 1 liter H2O. 
Lysis buffer: 50 mM NaH2PO4, 6.90 g N NaH2PO4·H2O (MW 137.99 g/mol), 300 
mM NaCl 17.54 g NaCl (MW 58.44 g/mol), 10 mM imidazole 0.68 g imidazole 
(MW 68.08 g/mol) in H2O then adjust pH to 8.0 using NaOH and finally to 1 liter 
H2O volume. 
Wash buffer: 50 mM NaH2PO4, 6.90 g NaH2PO4·H2O (MW 137.99 g/mol), 300 
mM NaCl 17.54 g NaCl (MW 58.44 g/mol), 20 mM imidazole 1.36 g imidazole 
(MW 68.08 g/mol) in H2O then adjust pH to 8.0 using NaOH and finally to 1 liter 
H2O volume. 
Elution buffer: 50 mM NaH2PO4, 6.90 g NaH2PO4·H2O (MW 137.99 g/mol), 300 
mM NaCl 17.54 g NaCl (MW 58.44 g/mol), 250 mM imidazole 17.00 g imidazole 
(MW 68.08 g/mol) in H2O then adjust pH to 8.0 using NaOH and finally to 1 liter 
H2O volume. 
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APPENDIX D: List of amino acids and their abbrevations 
Table D.1: List of amino acids and their abbrevations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
One - letter code Three - letter-code Name 
A Ala Alanine 
C Cys Cysteine 
D Asp Aspartic Acid 
E Glu Glutamic Acid 
F Phe Phenylalanine 
G Gly Glycine 
H His Histidine 
I Ile Isoleucine 
K Lys Lysine 
L Leu Leucine 
M Met Methionine 
N Asn Asparagine 
P Pro Proline 
Q Gln Glutamine 
R Arg Arginine 
S Ser Serine 
T Thr Threonine 
V Val Valine 
W Trp Tryptophan 
Y Tyr Tyrosine 
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